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         Nogo-A, the largest isoform of RTN4/Nogo, was originally identified as an 
inhibitor of neurite outgrowth of the central nervous system (CNS) and has received 
intensive studies. In addition, more and more novel functions have been recently 
found to be associated with Nogo molecules, including vascular remodeling, apoptosis, 
interaction with β-amyloid protein converting enzyme, formation/maintenance of the 
tubular network of the endoplasmic reticulum (ER), and so on. In order to understand 
the structure-function relationship of Nogo molecules, we initiated a systematical 
investigation of structural properties of Nogo molecules by a combined use of 
bioinformatics analysis, and biochemical and biophysical approaches. 
Firstly, two identified inhibitory domains (Ngogo-A_567-748 and Nogo-66) had 
been studies. CD and NMR characterization indicated that Ngogo-A_567-748 was 
partially structured while Nogo-66 was highly insoluble. Therefore, we targeted at 
buffer-soluble Nogo-40, which is a truncated form of Nogo-66 and was demonstrated 
as an NgR antagonist. Nogo-40 was flexible in the phosphate buffer while in presence 
of TFE Nogo-40 revealed two well-defined helices linked by an unstructured loop. 
The surprising discovery that buffer-insoluble protein domains could be easily 
solubilized in salt-free water allowed us to go back to determine the structure of Nogo-
60 in water. Nogo-60 adopted a structure with the N- and C-terminal helices 
connected by a long middle helix and it appeared that the packing between the C-helix 
and the 20-residue middle helix triggered the formation of the stable Nogo-60 
structure. Based on Nogo-60 structure, a structured and buffer-soluble Nogo-54 was 
successfully designed, which may hold promising potential to be used as a novel NgR 




antagonist to enhance CNS axonal regeneration. We further extended the structural 
study to the full-length of NogoA/B. Except for the helical loop of Nogo-66 and C-
terminal transmembrane domains, NogoA/B were predominantly unstructured in 
solution. We speculated that being intrinsically unstructured may allow Nogo 
molecules to serve as double-faceted functional players, with one set of functions 
involved in cellular signaling processes essential for CNS neuronal regeneration, 
vascular remodeling, apoptosis and so forth; and with another in 
generating/maintaining membrane-related structures.  
         Interestingly, proline rich N-terminus of Nogo-A/B possesses many short 
binding motifs. With the assistance of NMR spectroscopy and ITC, for the first time 
we identified a tight and specific binding between Nogo-A (171-181) and the third 
Nck2 SH3 domain with a Kd of 2.8 µM , which provides a novel clue for the 
investigation of the Nogo functions and its cross-talks with other Nck2-coordinated 
signaling networks such as Eph-ephrinB signaling.  
        In addition, we characterized the structural properties of 297-residue Nogo B 
receptor (NgBR).  Our results indicate that the NgBR ectodomain is intrinsically 
unstructured without both secondary and tertiary structures while the cytoplasmic 
domain is only partially folded with secondary structures but without a tight tertiary 
packing.  
In summary, this project leads to the establishment of a complete structural 
picture about Nogo proteins, which would not only facilitate the understanding of the 
mechanism of the diverse functions of Nogos, but also may have implications in drug 
design for human diseases associated with Nogos.  
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Chapter I.    INTRODUCTION 
 
 
1.1 .   Biological Background 
 
 
1.1.1.    Axonal Regeneration  
 
CNS (central nervous system) injuries, such as spinal cord injury, traumatic 
brain injury and stroke, are characterized by the failure of regeneration of the 
transected axons. Each year in the United States, more than 2 million people suffer 
from traumatic brain injuries, over 500,000 people suffer from stroke, and at least 
10,000 people suffer from spinal cord injuries. So far, the primary treatments are based 
on physical therapy and it is estimated that only 0.9 % of the patients will have 
completed neurological recovery. Therefore, there is a huge unmet medical need for 
treating CNS injury (Daniel et al., 2003). Understanding why the injured axon cannot 
regenerate in CNS is fundamental to the development of medical therapy. 
Unlike fish, amphibian, the mammalian peripheral nerves and developing 
central nerves, the adult central mammalian neurons fail to regenerate after injury. The 
consequences are not only interrupting the communication between healthy neurons, 
but also leading to neuronal degeneration and cell death (Philip et al., 2000). In the 
particularly favorable conditions, neuron in the adult CNS can regenerate. However, 
the regeneration rate of adult neuron is much slower than the elongation rate observed 
for the same neuron during the embryonic stages and this decrease in the ability of 
regeneration, parallel to neuronal maturation, also occurs in peripheral nerves system 




1.1.2.    Mechanisms underlying the failure of axonal regeneration in CNS 
      To achieve the success of axonal regeneration, a number of conditions must be 
fulfilled. The primary is the survival of neuronal soma. Whereafter, the injured axon 
should be able to re-form a new growth cone to reach its original target and make 
synapsis with it. Finally, the new connection has to be re-myelinated. Over the past 
several decades, the mechanism underlying the failure of regeneration of injured axons 
in CNS has been extensively investigated; however, the exact reasons are still not clear. 
Three broad categories of the hypotheses seek to explain this phenomenon: CNS 
neurons may lack sufficient intrinsic regenerative ability to allow prolonged axonal 
regeneration; the CNS may lack adequate supplies of neurotrophic molecules to 
support regenerating axons; and there may be inhibitory molecules in the CNS that 
block axonal regeneration (HUNT et al., 2003). 
 
1.1.2.1. Lack of intrinsic regenerative ability 
           Some intracellular changes responsible for the loss of the intrinsic ability of 
regeneration are identified. One critical change is the decrease of the expression levels 
of growth-promoting molecules in CNS, such as GAP-43 and CAP23 (Rossi et al., 
2001); while the expression levels of receptors for neurite outgrowth inhibitory 
molecules (such as NgR) increase after certain stages of development in CNS 
(Halabiah et al., 2005). Cyclic nucleotide levels also have observable changes. During 
neuronal development, high concentration of cAMP promotes axonal outgrowth 
through inactivation of Rho GTPase. However, after a particular point of the 
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development, the concentration of cAMP drops rapidly, which not only reduces the 
intrinsic ability of the neuron regeneration, but also increases growth cone’s sensitivity 
to axonal outgrowth inhibitory molecules (Cai  et al., 2001). 
 
1.1.2.2. Lack of neurotrophic molecules 
           Neurotrophins, secreted by cells in a neuron's target field, encourage survival of 
nervous tissue. Neurotrophins family includes nerve growth factor (NGF), brain-
derived neurotrophic factor (BDNF), neurotrophin 3 (NT-3), and neurotrophin 4 (NT-4) 
(Korsching 1993). Neurotrophins interact with two classes of receptors, p75 and the 
Tyrosine kinases. p75 can bind with almost all of the neurotrophins with low affinity; 
while the Tyrosine kinases only bind with specific neurotrophins but with a much 
higher affinity (Chao et al., 1995). The interaction between neurotrophin with its 
receptor results in cascades of signal transduction events that coordinate changes in 
cellular cytoskeleton and then in turn mediate the growth process. Many studies 
confirm the neurotrophins’ effect of both cell survival and axon growth-promoting 
after the injury to the adult CNS in vivo (Cui , 2006). 
Out of over 30 neurotrophic factors, six of them have been investigated as 
potential treatments for lesioned spinal cords in animal models. However, the clinic 
usage of neurotrophic factors is limited by the delivery problems and side effects. For 
example, although nerve growth factor (NGF) has the positive regenerative effects on 
peripheral nerves, it turned out to be clinically useless due to its effect of increasing 
sensitivity to pain (Schwab, 2002). 
 
5 
1.1.2.3. Inhibitory molecules in the CNS 
The lack of CNS regeneration was not only due to the absence of growth-
promoting factors in CNS neurons but also due to the presence of inhibitory molecules 
in CNS. This hypothesis has dominated during the past decades and leads to extensive 
investigation. The identified inhibitory molecules include the chondroitin sulfate 
proteoglycans (CSPG) Neurocan, Brevican, Phosphacan, Tenascin, and NG2, as either 
membrane-bound or secreted molecules; Ephrins expressed on astrocyte /fibroblast 
membranes; membrane-bound semaphorins (Sema) produced by meningeal fibroblasts 
invading the scar; and the myelin-associated inhibitors Nogo, MAG, and OMgp 
(Sandvig et al., 2004). Here we will particularly introduce the three myelin-associated 
inhibitory molecules, including the molecular structure, cellular location and the 
function related to the neurite outgrowth in CNS. 
 
1.1.2.3.1. MAG 
Myelin-associated glycolprotein (MAG), the first myelin-associated protein to 
be characterized as an inhibitor of axon outgrowth, is expressed by oligodendrocytes 
and Schwann cells in central and peripheral myelin respectively (McKerracher et al., 
1994; Mukhopadhyay et al., 1994; and Filbin, 1995). As a member of the 
Immunoglobulin Superfamily, MAG contains five Ig domains, a transmembrane 
domain and a short intracellular domain (Tropak et al., 1988). The primary sequences 
of MAG intracellular domain share no significantly homology with other proteins. The 
inhibitory effect of MAG in vitro is restricted to adult neurons, whereas in embryonic 
neurons MAG promotes neurons outgrowth. The dual nature of MAG activity is 
6 
regulated by intracellular cAMP levels (Cai et al., 2001).However, MAG knockout 
mice display little difference in terms of the regenerative ability of damaged spinal 
axons compared to wild-type mice (Bartsch et al., 1995). The role of MAG in 
neuronal regeneration in vivo has yet to be explored.  
 
1.1.2.3.2. Omagp 
Although identified in 1988 (Mikol et al., 1988), OMgp is the least known 
molecule of the three myelin-associated inhibitors (Kottis et al., 2002; Wang et al., 
2002). Omagp is expressed by oligodendrocyte myelin and neurons.  The mature 
OMgp consists of 401 aas, formed by four domains: one cystein-rich N-terminal 
domain, a leucine-rich repeat (LRR) domain, a serine-threonine rich domain, and a 
gycosyphosphatidylinositol (GPI)-link on its C-terminus. Through the GPI linkage, 
OMgp is localized to the outer leaflet of the plasma membrane. The experiments in 
vitro have shown that OMgp causes growth cone collapse and inhibits neurite 
outgrowth (Grados-Munro et al., 2003). The function of OMgp in vivo remains to be 
studied.  
 
1.1.2.3.3. Nogo (RTN4) 
The most widely studied myelin-associated inhibitor is Nogo (Chen et al., 
2000; GrandPre et al., 2000; Prinjha et al., 2000). Nogo (RTN4) is a member of the 
reticulon family. Reticulons (RTNs) are a relatively new eukaryotic gene family with 
ubiquitous expression and distinctive topological features (Figure 1.1b) (Oertle et al., 
2003). With the discovery of the first member RTN1, more than 300 family members 
7 
have been found in a variety of organisms (Oertle et al., 2003). In mammalian 
genomes four different reticulon genes RTN1, RTN2, RTN3 and RTN4/Nogos are 
identified. These genes encode a large number of isoforms that share homologies 
within the C-terminal region of 200 amino acids, called the reticulon-homology 
domain (RHD).  Although widely distributed, the functions of RTNs are still poorly 
understood. Most interests have been focus on RTN4/Nogo due to their involvement in 
various critical biological processed and association with the pathogenesis of human 
disease, especially the inhibition effect in CNS neuron regeneration.  
RTN4/Nogo (on human chromosomal 2p14-p13) gene generate three different 
isoforms, termed Nogo-A, -B and –C, by alternative promoter usage and /or splicing. 
Nogo-A, -B and –C proteins and mRNAs are expressed ubiquitously, although there is 
some tissue specificity. For example, NogoA is mainly expressed in brain and heart; 
NogoB is widespread on distribution; whereas NogoC is particularly abundant in 
muscle cells (Oertle  et al., 2003). As a member of RTNs, RTN4/Nogo proteins share a 
conserved C-terminal domain of 188 amino acids, consisting of two potentially 
membrane-spanning hydrophobic domains separated by a hydrophilic fragment of 66 
amino acids termed Nogo-66, followed by a 38-residue C-tail carrying endoplasmic 
reticulum (ER) retention motif. Accordingly, the majority of the Nogo proteins are 
localized to ER, with a small amount on the cell surface (Oertle et al., 2003). The N-
terminal regions of RTN4/Nogos are highly variable (Figure 1.1a). The 1192-residue 
Nogo-A is the largest isoform with an ~1016-residue N-terminus while the 373-
residue Nogo-B owns a N-terminus almost identical to the first 200 residues of Nogo-
A. The smallest variant Nogo-C consisting of 199 residues is made up of a very short 
8 
N-terminus plus the reticulon-homology domain (RHD) (Oertle  et al., 2003). 
Significant progresses have been made in identifying the inhibitory regions of 
Nogo-A. So far at least two main regions responsible for the neurite-growth-inhibiting 
effect have been identified: The first is a stretch in the middle of the unique N-
terminus of Nogo-A molecule (residues 544-725 for mouse and residues 567-748 for 
human Nogo-A proteins). The receptor for this inhibitory domain is still unclear.  The 
other is the extracellular 66 amino acid loop termed Nogo-66. Nogo-66 domain binds 
to the neuronal glycophosphatidylinositol (GPI)-linked NgR, via its leucine-rich repeat 
containing domain (Fournier et al., 2001). 
            Nogos-knockout mice have been intensively studied. Unexpectedly the results 
from three independent groups are not consistent. Kim’s group showed that the mutant 
lines lacking Nogo-A and –B displayed enhanced axonal regeneration after CST lesion 
accompanied by functional recovery (Kim et al., 2003); while the results from 
Simonen group were much more modest (Simonen et al., 2003). Moreover, Zheng’s 
group showed that mutant lines lacking Nogo-A, -B and –C display little enhanced 
axonal regeneration (Zheng et al., 2003). Currently, we cannot provide a convincing 
explanation for this divergence and this divergence has evidenced the need of further 
























                  
   
 
Figure 1.1. Three transcripts from the RTN4 and membrane topologies and 
subcellular localization of Nogo/RTN4. (a) The common C-terminus encodes the 
reticulon-homology domain (RHD), whereas the N-termini are specific for each 
isoform and have no obvious sequence homologies to other proteins. (b) Two 
proposed topologies for Nogo/RTN4. The lengths of the hydrophobic stretches (about 
35 amino acids) could allow them to span the membrane once or twice (Adapted from 






























1.1.2.3.4. Nogo receptor complex for Myelin-associated Inhibitory molecules  
       As Myelin-associated inhibitory proteins in CNS myelin have been demonstrated 
to play a role in axon regeneration following CNS injury, the identification of the 
receptor for these ligands is a crucial link in the molecular pathway. In 2001, this link 
— the Nogo-66 receptor (NgR, now also termed NgR1) — was identified (Fournier, 
2001). Not only does NgR bind to Nogo-66 with high affinity, but also it exhibits an 
expression pattern consistent with a role in CNS axonal regeneration. NgR is only 
expressed by the adult neurons while not by the early embryonic neurons. Interestingly, 
NgR also appears to be a functional receptor for MAG and OMgp. It seems that MAG, 
Nogo-66 and OMgp share the same binding sites on NgR and mediate their effects 
through the same pathways (Figure 1.2). Therefore, NgR is a focal point for the 
convergence of three myelin inhibitors (Barton et al., 2003). 
NgR is a 473 amino acid protein containing a signal sequence, a leucine-rich 
repeat (LRR)-type N-terminal domain(LRRNT), eight LRR domains, a cysteine-rich 
LRR-type C-terminal flanking domain (LRRCT), a unique C-terminal region, and a 
GPI anchorage site. Homologous proteins to NgR have now been identified as NgR2 
or NgRH1 (human 420 aa) and NgR3 or NgRH2 (human 441 aa) (Piqnot et al., 2003). 
There is about 50 % sequence homology between the NgR1-3. Both NgR2 and NgR3 
are expressed in the brain. Significant level of NgR2 expression is detected in the liver. 
Other peripheral tissues also show some level of NgR2. Despite the similarity in 
sequence and protein topology, NgR2 and NgR3 do not bind Nogo and Omgp. NgR2 
is identified as a novel receptor for MAG and acts selectively to mediate MAG 
inhibitory responses (Venkatesh  et al., 2005). The identity of natural ligands for NgR3 
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is unknown. The physiological roles of NgR2-3 need further investigation.  
The crystal structure of NgR1 (27aa-310aa) has beem determined and shows 
that β-sheet segments containing the LRRs are arranged in a parallel array, creating the 
concave surface of a banana-shaped structure. Based on the crystal structure of 
NgR1(310), it has been suggested that the evolutionarily conserved aromatic residues 
patches in the concave surface are probably degenerate ligand binding sites (Barton et 
al., 2003 and He et al., 2003). However, Dingyi Wen’s group showed that the 
published  structure for the LRRCT region of NgR310 was not representative of that 
found on the full-length NgR1. The three-dimensional model of NgR344 reported by 
this group indicated that the peptide comprising residues 310-334 folds back to the 
convex side of the LRRs of NgR1 (Wen et al., 2005).  
Because NgR1 lacks a cytosolic component, it would appear to require a 
transmembrane co-receptor to transduce an inhibitory signal. One of the co-receptors 
was identified as the neurptrophin receptor p75NTR (Wang et al., 2002). p75NTR 
associated with NgR1 through the C-terminus of LRR array of NgR1 and provided a 
direct link to Rho signal pathway. Further, Lingo-1 was identified as another 
component of the Nogo-66 receptor/p75 signaling complex (Mi et al., 2004). The 
crystal structure of ectodomain of human Lingo-1 which was just reported recently 
showed that either in the crystals or in solution Lingo-1 persistently axons 
regeneration associates with itself to form a stable tetramer. The large surface area of 





Figure 1.2. Molecular basis of Nogo-A mediated neurite outgrowth inhibition. 
NgR is a common receptor subunit for Nogo-A via Nogo-66, MAG and OMgp, and is 
complexed with p75 as a probable signal-transduction unit. A concomitant activation 
of the small GTPase RhoA and inhibition of Rac, as well as an elevation of 
intracellular Ca2+, are thought to be the main downstream signals of Nogo and other 
inhibitory proteins. RhoA might be activated in presence of p75. Experimental 
elevation of intracellular cAMP, which leads to protein-kinase A (PKA) activation, 
arginase-I upregulation and the synthesis of neurite-growth-promoting polyamines, as 
well as blockade of RhoA GTPase or of the Rho kinase Rock , can together abolish 










complex components during activation on the membrane (Mosyak et al., 2006).  In 
2005 two groups independently reported that an orphan receptor in the TNF family  
called TAJ (also known as TROY), broadly expressed in postnatal and adult neurons, 
binds to NgR and replaces p75 in the p75/NgR/LINGO-1 complex (Shao et al., 2005 
and Park et al., 2005). The relative role of these factors in preventing regeneration of 
axons after SCI is currently an active research area. 
The binding of myelin-associated inhibitory molecules (Nogo, Omag and 
MAG) to the NgR complex (p75/NgR/LINGO-1 or TAJ/ NgR/LINGO-1) transduces 
the signal that activates Rho A, whose effectors modify actin and microtubules and 
thus mediate neurite outgrowth and retraction (Etienne-Manneville et al., 2002). 
Although the receptor of the N-terminal domain of Nogo-A is still unknown, it was 
proposed that this domain of Nogo might also inhibit neurite growth by inducing the 
downstream activation of the small GTPase RhoA in responsive neurons (Figure1.2).  
 
1.1.2.3.5. Strategies to block myelin inhibitory molecules effects 
 
Since CNS regeneration is a multi-faceted problem, therapeutic strategies 
would involve a combination of attempts to directly enhance the intrinsic ability in 
CNS and neutralize the effect of inhibitors in CNS. Table1 summarizes the main 
therapeutic approaches currently used to promote axonal regeneration. Here we only 
focus on those blocking myelin inhibitory molecules effects, which can be done by 
blocking either the inhibitory molecules or their receptors.  
Blocking antibody The binding of the antibody to a protein could effectively block the 
interaction between the epitope protein and its binding partner. Actually, before the 
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molecular characterization of the Nogo-A antigen, IN-1 (anti-NogoA antibody) has 
been used to neutralize axonal growth inhibitors in myelin in many in vitro and in vivo 
studies. IN-1 was firstly generated by Schwab et al. using the rat CNS myelin NI250 
protein, a fragment of NogoA, as the immunogen (Caroni et al., 1988 ; Grandpre et al., 
2000). Through grafting of IN-1 hybridomas or direct administration of the IN-1 Fab 
fragment or humanized IN-1 antibody, axon functional recovery was significantly 
improved (Daniel et al., 2003). Recently, Martin E Schwab and Eric M Rouiller’s 
group used Nogo-A-specific antibody to treat macaque monkeys and reported that 
Nogo-A–specific antibody treatment enhances sprouting and functional recovery after 
cervical lesion in adult primates (Freund et al., 2006). In addition to Nogo-A antibody, 
antibodies against MAG and a monoclonal antibody against NgR also reduce myelin-
induced inhibition in vitro and effectively promote neurite outgrowth (Mukhopadyay 
et al., 1994; Li  et al., 2004). Although the in vivo efficiency still need further test, the 
therapeutic potential of these antibodies is apparent.  
Vaccination To avoid the problems associated with the antibody delivery, vaccination 
with purified myelin is used to permit the immunological neutralization of myelin-
associated inhibitors. The limitation of this approach is that it may result in the 
development of autoimmune disease. To minimize this risk, experiments have been 
carried out  using only recombinant protein as immunogens. Recombinant proteins, 
Nogo-66 and MAG, were used as immunogens to efficiently promote axonal 
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Antagonist peptides Antagonist peptide could also be an efficient approach to block 
the interaction between the ligand and the receptor. The peptide NEP1-40, consisting 
of the first 40 residues of the Nogo-66 loop of Nogo-A , behaves as an antagonist of 
NogoA to attenuate the effects of myelin or Nogo-66 on growth cone collapse and 
neurite outgrowth, and to improve the outcome in vivo after spinal cord injury 
(Grandpre, 2002). Another amazing antagonist peptide is NgR310, comprising the 
whole ligand binding domain but lacking the capacity to bind co-receptors. It could be 
one solution to effectively inhibit the action of all three myelin proteins interacting 
with NgR. The efficiency of NgR310 has been experimentally demonstrated (Li , 
2004). The latest report is related to Lingo-1 antagonist, the co-receoptor of NgR. 
Soulbe Lingo-1 fragment acts as an antagonist by blocking LINGO-1 binding to NgR1 
to promote functional recovery and axonal sprouting after spinal cord injury (Ji et al., 
2006). 
 
1.1.3.   Multiple biological functions of Nogos 
In this project, Nogo is the focus of our investigation. The function of Nogo as 
the inhibitor for axonal regeneration in CNS has been described detailedly in the 
previous sections. Here other diverse biological functions of Nogos will be 
summarized.    
 
1.1.3.1. Nogo in Apoptosis 
 
In 2001, Nogo-B was firstly identified as a novel apoptosis inducing gene (Li  et 
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al., 2001). They reported that Nogo-B, also called ASY, induced apoptotic cell death 
efficiently and preferentially in cancer cells. Experimental data indicated that this gene 
was effective to many types of cancer cells. However, in 2003, Thomas Oertle group 
investigated the effects of stable Nogo-B overexpression on the cellular proliferation 
rate and on the cells’ sensitivity to exposure to proapoptotic stimuli. Surprisingly, 
experimental data from Thomas Oertle group did not support the function of Nogo-B 
as a physiological proapoptotic protein in certain types of cancer (Oertle et al., 2003). 
The divergence of apoptosis function of Nogo-B remains to be further elucidated. 
Recently, Xiran Zhang’s group reported the newest finding that Nogo-C expressed in 
HEK293 could induce cell apoptosis. Their data firstly revealed Nogo-C induced 
HEK293 cell apoptosis by inducing caspase-3 and p53 activation through the JNK-c-
Jun-dependent pathway (Chen  et al., 2006). 
 
1.1.3.2. Nogos in ALS 
Amyotrophic lateral sclerosis (ALS) is a fatal neurological disease with 
clinical characteristics of selective degeneration of motor neurons and skeletal 
muscular fibers. The significant changes on both mRNA level and protein expression 
level of Nogos had been detected in postmortem muscular samples of ALS patients 
(Dupuis , et al., 2002) and further it was found that increased levels of Nogo-A and 
Nogo-B in muscle biopsies from 15 patients with ALS correlated with clinical 
disability and with the degree of muscle fiber atrophy (Jokic et al., 2005).  Therefore, 
Nogo is a potential biomarker for the ALS. Moreover, NogoA may play a role in the 
disease progress of ALS. It is already clear that blocking the interaction between Nogo 
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and the Nogo receptor can result in the re-growth and the repair of the injured nerve 
fibers. Since the degeneration of nerve fibers is one of the earliest changes in ALS, 
stimulating their re-growth may provide a novel therapeutic approach in ALS (Dupuis , 
et al., 2002). Future functional studies are required to explore the contribution of this 
gene to ALS pathology. 
 
1.1.3.3. Regulating K+ Channel Localization at CNS Paranodes 
Using immunoelectromicroscopy (IEM) and double immunofluorescence 
labeling, NogoA was found to be enriched at the paranodes of myelinatd axons, while 
Nogo-66 receptor NgR was not localized to the paranode. The distinctive localization 
pattern of NogoA and NgR at the paranodes raised the speculation that NogoA may 
interact with other receptors in specific axon-glial domains. Caspr, an adhesion 
molecule essential for the maintenance of the architecture of the axoglial apparatus at 
the paranodes (Girault, 2002), was identified to directly interact with Nogo-A via the 
extracellular Nogo-66 loop. Based on the experimental results from the pathological 
models, it was suggested that the interaction between NogoA and Caspr may play a 
role in modulating axon-glial junction architecture and possibly K+-channel 
localization during development (Du et al., 2003). 
 
1.1.3.4. Nogos in Multiple Sclerosis (MS)  
 
Multiple sclerosis is a chronic inflammatory disease of the CNS characterized 
by sharply demarcated areas of demyelination and axonal loss or damage, resulting in 
a multiplicity of neurological deficits (Magnusson et al., 2003). The etiology is still 
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uncertain, but the dominant hypothesis is that MS results from an autoimmune 
response against myelin components. Autoantibodies recognizing NogoA have been 
detected in MS patients. Two groups working independently addressed the role of 
Nogo in experimental autoimmune encephalomyelitis (EAE) (Karnezis et al., 2004 
and Fontoura et al., 2004). Both groups conducted EAE-induction experiments on 
Nogo A/B knockout mice and obtained the similar results that the deletion of Nogo 
gene resulted in EAE improvement. These findings have important implications for 
understanding the pathogenic mechanisms involved in autoimmune-mediated 
demyelization and in the development of new therapies for MS and other 
neurodegenerative disorder (Fontoura et al., 2006).  
 
1.1.3.5. Nogos in Alzheimer’s Disease 
Alzheimer’s disease (AD) is the most common neurodegenerative disease. The 
hallmark of Alzheimer’s disease is a progressive degeneration of the brain caused by 
the accumulation of amyloid β-peptide (Aβ). The first step in the production of Aβ is 
the cleavage of a membrane protein called the amyloid precursor protein (APP) by 
BACE (β-site APP-cleaving enzyme) (Hardy , 2002). As an ideal therapeutic target for 
the treatment of AD, BACE has been intensively studied and various inhibitors have 
been designed. Wanxia He group found that NogoB interacted with BACE to inhibit 
BACE activity and further to decrease amyloid-B peptide production. They also 
provided evidence that this interaction was extended to other members of the reticulon 
family and RTN3 is the principal BACE-interacting protein in human brain (He et al., 
2004). Two years later, this group mapped the interaction domains mediating the 
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binding between BACE1 and RTN/Nogos. They figured out that the C-terminal QID 
triplet conserved among mammalian RTN members was required for the binding of 
RTN to BACE1. Correspondingly, the C-terminal region of BACE1 was required for 
the binding of BACE1 to RTNS (He et al., 2006). This study provides insights into the 
regulation of BACE activity by RTNs and may have implications for therapeutic 
approaches. However, the physiological role for RTNs binding to BACE remains to be 
elucidated further.  
 
1.1.3.6. Vascular Remodeling 
 
Nogo-B was identified as regular of vascular remodeling in 2004 (Elaine, 
2004). Using a proteomic screening, Nogo-B was found to be enriched in intact blood 
vessels, smooth muscle cells, and endothelial cells, with its N terminus oriented 
extracellularly. In vitro, Nogo-B enhanced the migration of endothelia cell but 
inhibited the proliferation and migration of smooth muscle cell, all of which restrict 
the leision formation and are necessary for vascular remodeling. In NogoA/B deficient 
mice, vascular injury promotes exaggerated neointimal proliferation; while gene 
transfer of NogoB rescues the abnormal vascular expansion in those knockout mice. 
Two years later, Miao RQ’s group identified NgBR as the functional receptor for 
NogoB as the regulator of vascular remodeling (Miao et al., 2006). NgBR composes 
of a signal peptide sequence, a putative ectodomain, and a Type 1A transmembrane 
domain followed by a cytoplasmic domain. The functional study showed that NgBR 
colocalized with the Nogo-B during angiogenesis in vivo and mediates chemotaxis and 
3D tube formation of endothelial cells in vitro. The identification of NgBR facilitate 
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understanding the function of NogoB as a regulator of vascular remolding and may 
also lead to the discovery of agonists or antagonists of this pathway to regulate 
vascular remodeling and angiogenesis.  
 
1.1.3.7. A New Physiological Substratre for MAPKAP-K2 
The identifying Nogo-B as a new physiological substrate for mitogen-activated 
protein kinase-activated protein kinase 2 (MAPKAP-K2) introduces an additional 
level of complexity into the diverse function of Nogo (Simon, 2005). To date, there are 
four well-identified substrates for MAPKAP-K2, including HSP27 (Stokoe, 1992), 
hnRNP A0 (Rousseau S, 2002), CAPZIP (CapZ-interacting protein) (Eyers, 2005) and 
LSP1 (leucocyte-specific protein 1) (Huang, 1997). The phosphorylation of HSP27, 
CAPZIP and LSP1 regulate actin dynamics and cell motility (Eyers, 2005), while the 
phosphorylation of hnRNP A0 is related to the regulation of pro-inflammatory 
cytokines (Rousseau, 2002). NogoB was identified as a new substrate and the 
phosphorylation occurred at Ser107, which does not lie in the conventional MAPKAP-
K2 consensus sequence. As phosphorylation must occur in intracellular, this finding 
supports that Nogo is mainly associated with the ER (Simon, 2005). However, how 
phosphorylatio of Ser107 modifies the function of Nogo and mediates one or more 
MAPKAP-K2-dependent processes is still unknown.   
 
1.1.3.8. Endoplasmic Reticulum Tubule Formation 
As Nogos are found in almost all eukaryotic cells and organisms, they are 
proposed to exert basic function in cellular machinery (Oertle et al., 2003). Based on 
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the sequence analysis and expression location, Thomas Oertle and Martin E.Schwab 
speculated that Nogo might play in structural stabilization of the ER network. In 2006 
cell paper published the big discovery that the tubular network of the endoplasmic 
reticulum (ER) required the integral membrane protein Nogo-A. They used an in vitro 
system to address the mechanism of the ER tubular network formation. Their 
experiment data revealed that Nogos were largely restricted to the ER either in yeast 
or in mammalian cells. The deletion of NogoA in yeast led to the disruption of the 
peripheral tubular ER in stress situation. They also identified DP1, a conserved 
integral membrane protein, as a partner interacting with Nogo-A. The complex of 
NogoA and DP1 co-localized to the tubular ER and shared an unusual hairpin 
topology in the membrane. These “morphogenic” proteins partitioned into and 
stabilized highly curved ER membrane tubules (Gia, 2006). This great discovery not 
only reveals the basic function of Nogo in cellular machinery, but also provides insight 
into the generation of the characteristic structure of an organelle.  
 
In summary, Nogos have been implicated in a variety of critical cellular 
processes including CNS neurite regeneration, several neuron pathologies, apoptosis, 
vascular remodeling, interaction with β-amyloid protein converting enzyme, 
formation/maintenance of the tubular network of the endoplamic reticulum (ER) and 
so forth. Structural study of Nogo should be an indispensable requisite to understand 
the mechanism underlying the diverse functions of Nogo and essential for structure-




1.2.   Intrinsically Disordered Protein 
 
 
1.2.1. Reassessing the Protein Structure–Function Paradigm 
The protein structure-function paradigm was the cornerstones in the protein 
biology in the 20th century, which claims that a folded protein structure is necessary 
for its biological function (Dunker et al., 2001). This paradigm is now challenged 
based on systematic studies of intrinsically disordered proteins (Wright and Dyson 
1999; Dunker et al. 2001; Uversky 2002). In 1978, functional disorder was firstly 
indicated by X-ray crystallography and in the same year NMR also revealed the highly 
charged, functional tail of histone H5 to be disordered (Aviles, 1978). In 1996, a 
special term “native unfolded” was introduced to emphasize the existence of the 
proteins lacking any secondary structure under physiological condition (Weinreb, 
1996). Later, two alternative terms, “intrinsically unstructured” (Wright and Dyson, 
1999) and “intrinsically disordered” (Dunker et al., 2001), have also been used to 
describe these proteins. As NMR is more powerful in characterizing disorder than X-
ray diffraction, with the development of NMR as a structure tool the number of 
proteins and protein domains with little ordered structure under physiological 
conditions in vitro is rapidly expanding. In the Swiss Protein Database more than 
15,000 proteins were predicted to contain disordered regions of at least 40 consecutive 
amino acid residues, with more than 1050 of them having high disorder scores 
(Romero et al. 1998). Recent predictions on 29 genomes have established that proteins 
from eukaryotes have more intrinsic disorder than those from bacteria and archaea. 
More than 30% of eukaryotic proteins have disordered regions of more than 50 
consecutive residues. On the statistics in 2002, there were more than 100 proteins 
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belonging to natively unfolded proteins and these 100 proteins have at least 250 
homologs, which are also expected to be natively unfolded (Uversky, 2002). All these 
show that polypeptides without ordered structure under physiological are common, 
rather than exceptions. 
 
1.2.2. Characterizations of Intrinsically Disordered Proteins  
Typical intrinsically disordered proteins are distinguished from ordered 
proteins by some unique characteristics. They have specific amino sequence with low 
overall hydrophobicity, high net charge and low sequence complexity, compositional 
bias toward aromatic and hydrophilic residues. Differences in the amino-acid 
composition of ordered and disordered protein may result in or from evolutionary 
differences between these two types of protein. Evolutionary investigation of 28 
protein families containing ordered and disordered regions showed that only 3 families 
have disordered regions that evolve more slowly; while 20 of the families have 
disordered regions that evolve significantly more rapidly than their ordered regions 
(Brownet al., 2002).  
  Structurally, intrinsically disordered proteins have low content of ordered 
secondary structure and high intramolecular flexibility. Overall, they have larger 
hydrodynamic dimensions compared to typical native globular proteins with 
corresponding molecular mass. Most of intrinsically disordered proteins have the 




1.2.3. Biological Function of Intrinsically Disordered Proteins 
    Despite the fact that intrinsically disordered proteins fail to form fixed 3-D 
structure under physiological conditions, they carry out critically important biological 
functions. The intrinsically-unstructured proteins were proposed to be involved in 
special categories of functions including signal transduction, regulation, 
cytoskeletonal organization, protein-DNA recognition, human cancer, endocytosis and 
generating/ maintaining membrane structure (Dunker et al., 2002;  Iakoucheva et al. , 
2002; Dafforn et al., 2004;  and Gunasekaran, 2003). During these important 
biological processes, the flexible structure provides distinctive advantages, including 
(1) the possibility of high specificity coupled with low affinity (Dunker, 2001)  (2) the 
ability of binding to several different targets (Romero et al. 1998b) (3) the capability 
to overcome steric restrictions, enabling essentially larger interaction surfaces in the 
complex that could be obtained for the rigid partners (Uversky, 2002) (4) the precise 
control and simple regulation of the binding thermodynamic (5) the increased rates of 
specific macromolecular association , and (6) the reduced lifetime of intrinsically 
disordered proteins in the cell, possibly representing a mechanism of rapid turnover of 
the important regulatory molecules ( Wright & Dyson 1999). 
 
1.2.4. Methods to Characterize Intrinsically Disordered Protein 
 
1.2.4.1. Bioinformatics analysis 
With the great development of bioinformatics, protein structure prediction and 
function prediction from primary sequences provide valuable information for the 
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investigation of intrinsically disordered proteins. The Database of Protein Disorder 
(DisProt), including 15 predictors, provides structure and function information about 
intrinsically disordered proteins. So far DisProt (Release 3.4) contains 460 
intrinsically disordered proteins and 1103 disordered regions, encompassing 35 
functional categories. 
 
1.2.4.2. Experimental methods 
Intrinsically disordered protein has been investigated by several 
physicochemical methods, each owning its strongpoint and weakness. Some major 
techniques are briefly introduced below. 
NMR spectroscopy: NMR is an extremely powerful technique for structural 
characterization of the intrinsically disordered proteins. Using high-field NMR 
spectrometers, isotope-edited and triple-resonance pulse sequences experiments, NMR 
has overcome the problem of proton signal overlap that hampered early NMR studies 
of unfolded proteins and provides dynamics information on a residue-by-residue basis. 
Characteristic chemical shift deviations of Hα, Cα, and Cβ from random coil values 
are good indicators for the existence of random coil, α-helix or β-sheet (Dyson, 2004). 
Dihedral angles have also used to estimate the residual structure from the 
measurement of coupling constants. Another useful parameter is the 15N-1H 
hetereonuclear NOE, which gives positive values for (more slowly tumbling) ordered 
residues and relatively smaller value or negative values for (more rapidly tumbling) 
disordered residues (Dyson, 2004). 
X-ray crystallography: Disorder leads to missing electron density map in protein 
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structures determined by X-ray crystallography. The missing region existing as an 
ensemble of Ф, ¹angles indicates intrinsically disordered (Alber et al., 1982). 
However, without additional experiments, it is not sure whether a region of missing 
electron density is intrinsically disordered, or is the result of technical difficulties.  
Circular dichroism (CD) spectroscopy: CD spectrometer is a useful structure tool to 
distinguish ordered forms from disordered forms. Far-UV CD monitors the secondary 
structure; while near-UV CD is sensitive to the overall tertiary structure of the protein. 
This method is only semi-quantitative and does not provide residue-specific 
information; hence, the exact location of the ordered/disordered region in one protein 
cannot be identified only using this method (Uversky, 2002). 
Fluorescence characteristics Additional important information to the conformational 
description of the packing of a polypeptide could be extracted from fluorescence 
characteristics. The major fluorescence techniques includes FRET, steady-state and 
time-resolved parameters of the fluorescent dyes, accessibility of the chromophore 
groups to external quenchers, shape and position of the intrinsic fluorescence spectrum, 
and fluorescence anisotropy and lifetime. Similar to Circular dichroism (CD) 
spectroscopy, fluorescence techniques only provide the global information of proteins 
(Uversky , 2002). 
Protease digestion: Protease digestion is frequently used to give insight into protein 
structure and flexibility. Flexibility and surface exposure are two major determinants 
for digestion of possible cut sites. Although protease digestion is little used alone, it is 
especially useful when used in combination with other methods (Fontana A et al., 
1997 and Hubbard, 1998).  
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Hydrodynamic parameters:  Hydrodynamic parameters may help to determine  
protein is compact, or it has become unfolded. Techniques such as gel-filtration, 
viscometry measurement, SAXS, SANS, sedimentation, and dynamic and static light 
scattering are often used to obtain hydrodynamic parameters. The unfolding of a 
protein molecule results in an essential increase in its hydrodynamic volume (Uversky 
et al., 2000). 
Immunochemical methods may also be applied toward the elucidation of protein 
disorder. The immunoglobulin obtained against a given protein may be specific for 
different levels of macromolecule: the primary structure (Amit et al., 1985; Wilson et 
al., 1985), the secondary structure (Fujio et al., 1985), or the tertiary structure (Amit et 
al., 1985; Fujio et al., 1985; Wilson et al., 1985). Thus, antibodies may be 
successfully used to study the structural changes (Uversky VN , 2002). 
        Besides the methods mentioned above, there are still a lot of useful tools for 
intrinsically disorder proteins analysis, such as Fourier transform infrared, Raman 
spectroscopy and Raman optical activity, electron microscopy or atomic force 
microscopy, the charge state analysis of electrospray ionization mass-spectrometry, 
and so on.  Combination of these methods will greatly help us to understand 







1.3 . PROTEIN STRUCTURE DETERMINATION BY NMR 
 
Nuclear magnetic resonance (NMR) spectroscopy is considered to be one of 
the most powerful techniques for 3D structure determination of proteins and nucleic 
acids. The important role of NMR in structural biology is illustrated by more than 
6000 NMR solution structures deposited in the protein data bank. The development of 
high-field supraconducting magnets, the improvement in radiofrequency electronic 
and NMR probe design make great contribution to obtain high spectrum resolution 
and allow sophisticated pulse sequences to be applied. Multidimentional NMR 
spectroscopic techniques are in continuous development in which properties of both 
isotope labeled nuclei and nuclei in their natural abundance are exploited and 
abundant structural information thus can be derived from NMR spectrum. Meanwhile 
advanced computers and powerful workstations make experiments controlling and 
data processing easier in a reasonable time (Jeremy N.S Evans , 1995).  
 
      1.3.1. Unique features of NMR 
NMR and X-ray are the two techniques that can provide structure of molecules 
at atomic resolution. Both techniques are well established and play key roles in 
biological research. Compared with X-ray crystallography, NMR spectroscopy has 
some unique properties. X-ray crystallography requires single crystals while NMR 
measurements are carried out in solution. Thus, solution conditions including the 
temperature, pH and salt concentration can be easily adjusted to either physiological 
condition or extreme non-physiological conditions for different study aims.  
Furthermore, NMR measurements not only provide structural data but can supply 
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information on dynamics, conformational equilibria, folding and intermolecular 
interactions.  
 
1.3.2. NMR Phenomenon 
Nuclear magnetic resonance occurs when the nuclei of certain atoms are 
immersed in a static magnetic field and exposed to a second oscillating magnetic field. 
Whether the nuclei experience this phenomenon depends on the nuclear spin property 
of the nuclei. Nuclear spin (I) is the angular momentum quantum number, a 
fundamental property of a nucleus. Nuclei with 0=I  (like 12C, 16O) have no magnetic 
moment and thus are NMR inactive. Nuclei with 21=I  (like 1H, 15N, 13C) can give 
simple and interpretable signals and thus are widely used in NMR. Nuclei with 
21>I  (like 2H, 14N) possess electric quadrupolar moment besides their magnetic 
moment. The electric quadrupolar moment interacts with electric field and produces a 
very efficient mechanism for nuclear spin relaxation and leads to NMR signal 
broadening and even no NMR signal could be detected. In an external magnetic field, 
spin of ½ can orient parallel or antiparallel to the external magnetic field.  The two 
possible orientations correspond to slightly different energies. Spins are allowed to 
jump from one orientation to the other, absorbing or emitting the energy difference in 
the form of electromagnetic radiation. The difference between the number of parallel 
and anti-parallel spins contributes to the NMR signal. NMR signal sensitivity is 
directly related to gyromagnetic ratio γ, another intrinsic property of a nucleus.. 
Among the three widely utilized nuclei, 1H has the largest magnetogyric ratio γ 
(γ1H/γ13C is bout 4 and γ1H/γ13N is about 10) (Roberts, 1970; Wuthrich  1986). 
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1.3.3. Chemical shift 
The chemical shift is one of the most basic parameters of NMR. Chemical shift 
is caused by electric de-shielding effect. Electrons around nuclei creat a small 
magnetic field which shields nuclei from the external field, which results in that nuclei 
with different chemical environment will have different resonance frequencies and 
appear in the spectrum at different positions. In NMR spectrum, each nucleus with its 
unique chemical environment is characterized by unique chemical shift. Thus 
Chemical shift is an important parameter for identifying individual nucleus and 
assigning the resonances in the spectrum to its site in chemical structure (Wuthrich  
1986). Moreover, chemical shift provides useful information in identifying protein 
secondary structure. Characteristic chemical shift deviations of Hα, Cα, and Cβ from 
random coil values are good indicators for the existence of α-helix or β-sheet (Figure 
1.3) (Wishart et al., 1991).  
 
1.3.4. J coupling 
Nuclei that are connected by covalent bonds will exert magnetic interactions 
on each other, resulting in mutual splitting of the NMR signal from each nucleus into 
multiplets. This phenomenon is called J coupling, also known as scalar-, indirect-, or 
spin –spin coupling. In practice, the effects of J coupling can be observed if the 
number of bonds connecting the nuclei is three or less. Combined with chemical shift, 







        
 
        Figure 1.3. Chemical shift deviations of Hα, Cα, Cβ from random coil       

















             
                        Figure 1.4.  NOE patterns associated with secondary structure 










acids, which are helpful to identify amino acid types. Moreover, the 3J coupling 
constants are related to the dihedral angles via the Karplus equation. 3JNHHα and 3JHαHβ 
are widely used to determine the torsion angles Ф and χ1, thus providing important 
information on conformations of peptide backbone and amino acid side chains. 
Similar to chemical shift deviation of residues in structured region from those in 
random coil, deviation of 3JNHHα values from random coil values provides valuable 
secondary structural information. In folded proteins, β-Structures are characterized by 
large coupling constant values in the range 8~10 Hz, while α-helical structures are 
characterized by values in the range 3~5 Hz. In unfolded proteins, however, the 
coupling constants are about 6~7.5Hz due to the fact that conformational fluctuation 
averages the coupling constants (Dyson et al, 2001).  
 
1.3.5. Nuclear Overhauser Effect (NOE) 
           The phenomenon of Overhauser effect is discovered by Alber Overhauser in 
1953. The nuclear overhauser effect (NOE) is defined as the NMR signals intensity 
changes produced by dipolar cross-relaxation from neighboring spins, which can 
normally be detected between nuclei separated by a distance of less than 5Å. NOE is 
proportional to the inverse sixth power of the distance between the interacting dipole 
moments (1/r6).  NOE intensities can be converted into distance constraints between 
nuclei, thus playing a central role in the protein 3D structural determination. In general, 
NOE intensities are classified into three different categories, with distances of 1.8-2.7 
Å, 1.8-3.3 Å, and 1.8-5.0 Å for strong, medium, and weak NOEs respectively. NOEs 
not only provide information for establishing connection among amino acids, but also 
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reveal protein secondary and tertiary structure (Figure 1.4) (Jeremy N.S Evans, 1995). 
 
1.3.6. NMR Relaxation Parameters 
As mentioned above, NMR is a unique and powerful tool in studying protein 
dynamics. T1(spin-lattice), T2 (spin-spin)and steady state heteronuclear NOE are the 
most commonly used NMR relaxation parameters to report the internal motions on 
fast and slow timescales as well as the overall rotational diffusion of the molecule. 
After a 90º plus is applied to the equilibrium longitudinal magnetization, 
transverse magnetization is created while z-magnetization disappears. Thus, the 
system is in a non-equilibrium state and will relax back to the equilibrium state. This 
relaxation process is described by two parameters T1 and T2. T1 is defined as the 
component of relaxation that occurs in the direction of the ambient magnetic field and 
T1 generally comes about by the interaction between the nucleus of interest and 
unexcited nuclei in the environment and electric fields in the environment. T2 is 
defined as the component of 'true' relaxation to equilibrium occurring perpendicular to 
the ambient magnetic field. Therefore the relaxation is dominated by interactions 
between spinning nuclei which are already excited (Joseph P. Hornak, 1996).   
T1, T2 measurement  experiments involve recording a series of high resolution 
15N-1H (for backbone) or 13C-1H (for sidechain) correlation maps with the intensity of 
each correlation attenuated by 1H relaxation as a function of delays characterizing the 
appropriate relaxation parameter (T1 or T2). The decay of intensities was fitted 
monoexponentially to obtain the relaxation time constants T1 and T2 .  
Heteronuclear NOE ({1H}-15N-heteronuclear NOE, hetNOE) is a special case 
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of the NOE experiment where magnetization is transferred from 1H to a heteronucleus. 
The NOE is actually a cross-relaxation rate, in that non-equilibrium states of one 
nucleus affects other nuclei. Since the NOE transfer rate depends on dynamics, the 
{1H}-15N-heteronuclear NOE is a very convenient way to identify flexible residues 
which have low hetNOE values. For the measurement of heteronuclear NOE, two 
spectra were collected with or without proton saturation. The correct ratio of the 
respective peak intensities provides steady state NOE (Szyperski et al., 1993). 
 
1.3.7. General strategy of NMR structure determination 
         Structure determination by NMR is an established technique and is routinely 
used to determine 3D structures of biological macromolecules in solution. Figure 1.5a 
presents the outline of the general strategy for protein structure determination by NMR.  
 
1.3.7.1 Protein sample preparation 
         The first step in protein structure determination is preparation of the protein 
sample in solution. The protein is overexpressed in special medium enriched with 15N 
and/or 13C isotopes.  An efficient structure determination by NMR requires a highly 
purified and stable protein sample. The pH, ionic strength, and temperature are 
adjusted to optimize the protein behavior in solution. Milligram amounts of protein are 
required for NMR measurements. Usually, the protein is dissolved in around 0.4-0.5 







Figure 1.5. Strategy of structure determination by NMR.  
Outline of the general strategy used to solve the three-dimensional structure of 







1.3.7.2. NMR spectroscopy 
       The second step is to record high quality NMR spectra. In protein structure 
determination, 1D spectrum is crowded with overlapping signals to an extent where 
analysis is impossible. Therefore multidimensional (2D, 3D, even 4D) spectra are 
measured to deal with this problem. A set of heteronuclear multidimensional 
experiments are recorded for chemical shifts assignments (1H, 15N, 13C). The most 
important experiment is recording NOESY spectra to measure distances between pairs 
of atoms within the molecule. Usually, the NMR measurements for protein structure 
determination are performed on a spectrometer operating at a proton resonance 
frequency of at least 500 MHz.  The spectra raw data are required to be processed 
using Fourier transformation to obtain frequency domain data. Subsequently, the 
processed spectra are used for assignments.  
 
1.3.7.3. Resonance assignment 
          Assignment is the process of attributing a resonance in an NMR spectrum to a 
particular nucleus in a molecule. The first step in assignment is the identification of 
certain amino acids with a characteristic pattern of cross signals. The second stage of 
assignment is to search the sequential contacts from the already identified amino acids 
to the neighboring ones in the NOESY spectra. Inter-residual cross signals can be 
distinguished from the intra-residual ones by comparing the NOESY with the TOCSY 
































1.3.7.4. Collection of conformational constraints 
         Geometric conformational information is necessary for protein structure 
determination. In addition to NOE-derived distance restrains, other constrains that are 
often utilized in the structure calculation include 3J-coupling constants, residual 
dipolar coupling, torsion angles and hydrogen bond. The quality of a solution structure 
increases with the number of consistent input constraints.  
 
1.3.7.5. Calculation of the 3D structure 
       Once conformational constraints are got, the computer converts these constraints 
into a visible structure. This process is called structure calculation. A randomly folded 
starting structure is calculated from the empirical data and the known amino acid 
sequence. The computer program then tries to fold the starting structure in such a way, 
that the experimentally determined inter-proton distances are satisfied by the 
calculated structures. The computer program tries to calculate a structure with a 
possibly small overall energy. Two in principle different methods are employed for 
calculating a protein structure in solution. One is distance geometry (DG). In this 
method, the computer calculates the matrices of distance constraints for each pair of 
atoms from all available distance constraints, bond and torsion angles as well as van 
der Waals radii. Then the set of distances is projected into the three-dimensional space 
of a Cartesian coordinate system. Another method is simulated annealing. This is a 
molecular dynamics method, which takes place directly in the Cartesian coordinate 
system. In this method, a starting structure is heated to a high temperature in a 
simulation. During many discrete cooling steps the starting structure can evolve 
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towards the energetically favorable final structure under the influence of a force field 
driven from the constraints (Jeremy, 1995) . 
       
1.3.7.6. Evaluation of structure quality 
          After structure calculation, the final step is to assess the structure quality. 
Normally the following three parameters are important criteria to check: constraints 
violations, the RMSD (root mean square deviation) of the structure ensemble and the 
Ramachandran plot (phi and psi-angles of the protein backbone). The good quality 
structure should have little constraints violation, small RMSD and most phi and psi-
angles should be within the allowed region of Ramachandran plot. PROCHECK is the 
most popular program for assessing the quality of a given protein structure (Laskowski 














As mentioned above, Nogos has been implicated in a variety of critical biological 
processes and association with the pathogenesis of human diseases. However, so far there is 
little structure information about Nogos. The aims of this research were to investigate 
the structural characteristics of Nogos and also to study the interaction between Nogos 
and the binding partners:  
1. One purpose of this research was to determine the structure of the functional 
domain of Nogo. Structural characteristics of the two inhibitor domains, Nogo-A 
(567-748) and Nogo-66, will be investigated by NMR.  
2. Another purpose was to gain insight into the structural characterisics of the full 
length NogoA/B. As Nogo-A contains 1192 residues, the full length NogoA will be 
systematically dissected into smaller fragments and the structure characterisics of 
these fragments will be investigated.  
3. The interaction between Nogos and the binding partners was another focus in this 
research. NMR is a very powerful tool to detect the binding between Nogo 
fragments and the potential binding partners.  
The results of this research should be of significant value in the search of axon 
regeneration in CNS and also in the understanding of the diverse functions of Nogos 
in a various critical biological processes.  The major contributions of this research are 
as follows:  
1. The solution structure determination of the functional domain of Nogo should 
offer a starting point for understanding the interaction between Nogo and the 
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binding partners. 
2. The structure of Nogo functional domain should offer useful clues to further 
design of molecules to enhance CNS neuronal regeneration. 
3. Identification of new binding partner may offer a critical molecular clue for 































































































Chapter II.  Material and Method 
 
 
2.1. Vector Construction 
The gene of Nogos was obtained by PCR using a Nogo-A cDNA (designated 
KIAA0886) from the Kazusa DNA Research Institute (Janan). The PCR product and 
vector (pET32a or pGEX-4T-1) were double digested by BamH I and Xho I (New 
England Biolab) at 37 ℃ for 3 hours and subsequently purified by QIAquick Gel 
Extraction Kit (Qiagen). Ligation was then carried out at 4 ℃ for 48 h in the presence 
of T4 DNA Ligase (New England Biolab). The ligation product was transformed into 
E.coli DH5α for colony screening. Plasmids were amplified in E.coli DH5α and 
purified by QIAprep Spin Miniprep Kit 250 (Qiagen). All of the above performances 
followed the protocols provided by the manufacturers. All the procedures were 
monitored by Agarose DNA electrophoresis (Bio-Rad). Positive colonies were 
selected and confirmed by PCR and double digestion. The DNA sequence was 
confirmed by automated DNA sequencing.  
 
2.2. Preparation of Competent E.coli Cells 
Overnight culture of DH5α or BL21 cells was diluted into 50 ml fresh LB 
broth (Bio Basic Inc.) at a ratio of 1:100. Cells were grown at 37 ℃ with shaking till 
OD600 reached 0.5~0.6. Then cells were transferred into sterile centrifuge tubes and 
spun down at 4000*g for 5 min. The cell pellet was then gently resuspended with 
0.5 volumes (25 ml) of ice cold, sterile, fresh 50 mM CaCl2 (Merck) and 
immediately incubated on ice for at least 20 min. After that, cells were centrifuged 
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down again at 4000*g for 5 min. After discarding the supernatant, cells were 
resuspended with 0.1 volumes (5 ml) of cold 50 mM CaCl2 containing 10 % 
glycerol (BDH Laboratory Supplies). Cell resuspension was then distributed in 
aliquots into 1.5 ml sterile eppendorf tubes. Competent cells were stored at -80 ℃ 
after quick frozen by liquid nitrogen.  
 
2.3. Transformation of E. coli Cells 
 
1~3 µl plasmid DNA (about 150 ng/µl) was added to a tube containing 100 µl 
of E coli.  competent cells and mixed well by gently tapping. The cells was then 
incubated on ice for 20-30 min, followed by a heat shock at 42 ℃ for 75 seconds and a 
subsequent incubation on ice for 2 min. Then 800 µl of LB was added to the tube and 
incubated at 37 ℃ for 60 min before plating cells onto LB plates containing ampicilin. 
 
2.4. Protein Expression and Purification 
The recombinant his-tag proteins of Nogo-A dissection fragments were 
expressed in the bacterial strain BL21. Briefly, the cells were cultured at 37 ℃ to an 
OD600 of 0.6. IPTG was then added at a final concentration of 0.4 mM to induce the 
recombinant protein expression 8 hours at 20 ℃.  Then the recombinant proteins were 
purified by Ni2+-affinity chromatography under native conditions and subsequently 
were purified by HPLC on a reverse-phase C4 column. 
The recombinant GST Nogo peptides were expressed in the bacterial strain 
BL21. Briefly, the cells were cultured at 37 ℃ to an OD600 of 0.6. IPTG was then 
added at a final concentration of 1.0 mM to induce the recombinant protein expression 
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4 hours at 37 ℃. The recombinant GST fusion protein were purified by Glutathione-
Sepharose 4B resin under native conditions and subsequently were purified by HPLC 
on a reverse-phase C18 column. 
Nogo-66, Nogo-60 Nogo-54 and Nogo21-60 His-tag protein were induced at 
37 ℃ until OD600 reached 0.6. The concentration of IPTG was 1.0 mM. After 
incubation for 4hours, cells were harvested and the inclusion body was dissolved by 8 
M Urea. The recombinant his-tag protein was purified by Nickle resins under denature 
condition and subsequently was purified by HPLC on reverse-phas C18 column.  
 
2.5. Preparation of Isotope Labeled Proteins 
For heteronuclear NMR experiments, 15N-labeled proteins were prepared 
following the similar expression and purification procedures except for growing 
E.coli cells in the M9 minimal medium (Na2HPO4•12H2O 17.1 g/L (J. T. Baker); 
KH2PO4 3 g/L (J. T. Baker); NaCl 0.5 g/L; (15NH4)2SO4 1 g/L (Cambridge Isotope 
Laboratories Inc.); Glucose 4 g/L (Sigma); MgSO4 1 mM (Merck); Thiamine 2 
mg/L (Sigma); ampicillin 75 mg/L). The (15NH4)2SO4 salt was used for 15N labeling 
and for 13C labeling, labeled Glucose (2g/L) was used.  
 
2.6. Protein Analysis by SDS-PAGE 
  
SDS-polyacrylamide gel electrophoresis was performed using Hoefer Mighty 
Small II electrophoresis unit (Amersham Pharmacia Biotech). Low range prestained 
SDS-PAGE standard was from Bio-Rad, in which molecular weights of marker 
proteins were 6.5, 14.4, 21.5, 31, 45, 66, 97.4KD respectively. After electrophoresis, 
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SDS-PAGE was placed in staining solution (0.025  % Coomassie brilliant blue R250; 
40 % methanol; 7 % acetic acid) for about 20 min with gentle shaking. Then, the 
PAGE was transferred to destaining solution I (40 % methanol; 7 % acetic acid) for 20 
min, followed by transferring to destaining solution II (5 % methanol; 7 % acetic acid).  
 
2.7. Determination of Protein Concentration by Spectroscopy 
The concentration of a protein solution is usually determined by measuring 
the absorbance, A, near 280 nm and using the Beer-Lambert Law: ClA ∗∗= ε , 
where ε  is the molar absorption coefficient (M-1cm-1), l is the path length (cm), and 
C is the protein concentration (M). The absorption A of a protein at 280nm depends 
on the content of Trp, Tyr, and Cys (disulfide bonds), extinction coefficient ε can be 
determined by following equation : 
)125)((#)490,1)((#)500,5)((#))(280( 11 CystineTyrTrpcmM ++=−−ε . 
Here, #Trp, #Tyr and #Cystine are the numbers of each corresponding residue in a 
protein. (Pace et al., 1995) 
Proteins were denatured in 6 M guanidine hydrochloride, followed by A280 
measurements by UV/visible spectrophotometer using 0.1 mm quartz cuvette.  
 
2.8. CIRCULAR DICHROSIM SPECTROSOPY 
CD experiments were performed on a Jasco J-810 spectropolarimeter equipped 
with a thermal controller. The far-UV and near UV CD spectra of the samples were 
collected at 20 ℃at peptide concentrations of 10-50 µM using 1 mm path length 
cuvettes with a 0.1 nm spectral resolution. Data from five independent scans were 
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added and averaged. Thermal unfolding spectroscopy was recorded from 5 ℃ to 95 ℃ 
continuously. 
 
2.9. Isothermal calorimetry (ITC) 
All ITC calorimetric titrations were performed using a Microcal VP ITC 
machine. The proteins were in the 50 mM Tris buffer (pH 7.0), with 3 mM 2- 
mercaptoethanol. After centrifugation for 15 min, the samples were degassed for 15 
min to prevent the bubble formation. The third hNck2 SH3 samples with a 
concentration of 0.025 or 0.05 mM were placed in the 1.4 ml reaction cell and 1.0 mM 
Nogo-A peptide was loaded into the 296.4 ml injection syringe. All titrations were 
performed at 25 ℃ and obtained data were fitted using the built-in software ORIGIN. 
 
2.10. Fluorescence 
All fluorescence measurements were made using a Perkin-Elmer LS-50B 
luminescence spectrometer. Cuvette with 0.5 cm path-length was used. The protein 
concentration was kept constant at 5 µM in buffer. The excitation and emission 
bandwidths were 5 and 3 nm respectively. The excitation wavelength was set at 280 
nm and the spectra were recorded from 300 to 400 nM.  
 
2.11. NMR Sample Preparation and Experiments 
The systematically dissection of NogoA fragments and NogoB dissection 
fragments were prepared in a pH 6.8 buffer consisting of 50 mM phosphate, 0.01 % 
(w/v) sodium azide and 5 mM DTT, with an addition of 10 % D2O for the lock. The 
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proline-rich peptides were dissolved in the same buffer except that no DTT was added 
for those containing no cysteine in the sequences. Buffer insoluble proteins, including 
Nogo-66, Nogo-60 and Nogo21-60 were prepared by dissolving the lyophilized Nogo 
peptides in 450 μl Milli-Q water with an addition of 50 μl D2O for NMR lock. The 
sample pH was adjusted to 4.0 by adding 1-2 μl of NaOH (100 μM). Nogo-54 samples 
in buffer were prepared by dissolving it in 10 mM phosphate buffer at different pH.  
Nogo-40 in either (50:50, v/v) trifluoroethanol-d3/H2O or trifluoroethanol-
d3/D2O in the presence of 50 mM phosphate (final pH or pD ~ 6.5). The deuterium 
lock signal for the NMR spectrometers was provided by the addition of 10 % D2O. 
NMR experiments were acquired on an 800 MHz Bruker Avance spectrometer 
equipped with pulse field gradient units or 500 MHz Bruker Avance spectrometer 
equipped with both an actively shielded cryoprobe and pulse field gradient units. The 
NMR spectra acquired for both backbone and side-chain assignments included 15N-
edited HSQCTOCSY, HSQC-NOESY, as well as tripleresonance experiments 
HNCACB, CBCA(CO)NH, HNCO, (H)CC(CO)NH, H(CCO)NH and HCCH-TOCSY. 
NOE restraints for structure calculation were derived from 15N- and 13C-NOESY 
spectra. The NOE constraints involved in the aromatic side chains were collected from 
two-dimensional 1H NOESY spectra in D2O. NMR data were processed with 
NMRPipe and analyzed with NMRView. 
               15N T1 and T2 relaxation times and {1H}–15N steadystate NOEs were 
determined on the 800-MHz spectrometer at 278 K as described previously (Kay et al. 
1989; Clore et al. 1990; Farrow et al. 1994). 15N T1 values were measured from 
HSQC spectra recorded with relaxation delays of 10, 50, 75, 100, 125, 150, 200, 250, 
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and 500 msec. 15N T2 values were determined with relaxation delays of 10, 60, 100, 
150, 180, 210, 240, and 300 msec. {1H}–15N steady-state NOEs were obtained by 
recording spectra with and without 1H presaturation of duration 3 sec plus a relaxation 
delay of 5 sec at 800 MHz. 
 
2.12. NMR Structure Determination 
 
For Nogo-40 structural calculations, NOE connectivities were collected from 
NOESY spectra of Nogo-40 in TFE/H2O or TFE/D2O mixtures. All NOE data were 
grouped into four categories: strong, medium, weak and very weak, corresponding to 
upper bound interproton distance restraints of 3.0, 4.0, 5.0 and 6.0 Å, respectively. The 
sum of the Van der Waals radii of 1.8 Å was set to be the lower distance bound. Due to 
resonance line broadening, or overlap or small 3JHNH or both, the measurement of 
3JHNHα based on a DQF-COSY spectrum is mostly unsuccessful. Therefore, the 
backbone dihedral angles were set to center at -60 ℃ for residues having both αN(i+3) 
NOEs and large helical conformational shifts. The solution structure of Nogo-40 was 
calculated on a Linux-based PC station by using the simulated annealing protocol in 
the CNS program. The structures were analyzed by InsightII and MolMol graphic 
softwares. 
For Nogo-60 structure calculation, a set of manually-assigned unambiguous 
NOE restrains together with dihedral angle restraints predicted by TALOS program 
based on chemical shift values (Hα) was used to calculate initial structures of Nogo-60 
by CYANA program. With the availability of the initial structure, more NOE cross-
peaks in the NOEST spectra were added in the structure calculation. After many 
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rounds of refinement, the final set of unambiguous NOE and dihedral angle restraints 
were utilized for structure calculation. The 20 lowest-energy structures selected by 
CYANA were analyzed by the graphic software MolMol. The NME structure of Nogo-
60 was deposited at the Protein Datta Bank.    
 
2.13. HSQC Characterization of the Binding between the  SH3 Domains with 
Nogo-A Fragments 
 
To characterize the binding interactions between the hNck2 SH3 domains and 
Nogo-A fragments, two-dimensional 1H-15N HSQC spectra of the 15N-labeled SH3 
domains were acquired as previously described at a protein concentration of ~100 µM 
in the absence or in the presence of Nogo-A fragments at a molar ratio of ~1:4 for 
initial detections and ~1:2 for the final mapping of the binding interfaces 
(SH3/peptide). The perturbed residues were assigned by superimposing the two HSQC 





















































                 3.1. Structural Characterization of  
















           As mentioned in the introduction part, so far at least two inhibitory regions are 
identified. The first is a stretch in the middle of the Nogo-A molecule (residues 567-
748 for human Nogo-A proteins) and the second is the extracellular 66 amino acid 
loop called Nogo-66 (66 residues 1055-1120) (Figure3.1.1). In the first stage of this 
study, we cloned and expressed these two functional regions of the human Nogo-A 
and performed structural characterization by CD and NMR spectroscopy. 
 
3.1.1. Expression and structural characterization of NogoA-(567-748) and Nogo-66 
 
          The DNA fragments encoding Nogo-A-(567-748) and Nogo-66 were generated 
by PCR and successfully cloned into pET32a/pET-15b vectors and expressed as His-
tagged proteins. As shown in Figure 3.1.2, the Nogo-A-(567-748) protein were 
purified by Ni2+-affinity chromatography under native conditions while the Nogo-66 
protein was purified under denaturing conditions because Nogo-66 was expressed into 
the inclusion body. Attempts to refold Nogo-66 by dialysis and fast dilution were 
unsuccessful, indicating that Nogo-66 is highly insoluble. The molecular weight of the 
182-residue NogoA-(567-748) was determined by MALDI-TOF mass spectrometry, 
which is consistent to the predicted MW from the amino acid sequence. Interestingly 
the apparent molecular weight of NogoA-(567-748) estimated by SDS-PAGE (Figure 
3.1.2a) was about ~37 KDa, much larger than that expected for a 182-residue protein. 
This anomalous behavior on SDS-PAGE has been previously observed for cloned 
Nogo-A fragments and was attributed to the existence of a high number of charged 






   
 
Figure 3.1.1. Schematic representation of the domain organization of the human 
Nogo-A protein (a)  the domain organization of the human Nogo-A showing the N-
terminal stretch region Nogo-A-(567-748) and the extracellular 66 amino acid loop 
Nogo-66 with growth cone collapsing functions. The black boxes indicate 
transmembrane domains. (b) the amino acid sequence of Nogo-40 (c) the amino acid 

























Figure 3.1.2. Expression and purification of Nogo-A-(567-748) and Nogo-66 
 
(a) Coomasie brilliant blue stained SDS-PAGE gel showing the expression and 
affinity-purification of the human Nogo-A-(567-748) protein: Line 1: total cell extract 
before IPTG induction; Line 2, total cell extract after 0.5 mM IPTG induction at 20º C 
overnight; Line 3: Supernatant of the cell lysate after high speed centrifugation; Line 4: 
pellet of the cell lysate after high speed centrifugation; Line 5: Ni-Agarose beads with 
bound NogoA-(567-748); Line 6: protein molecular weight markers; Line 7, affinity-
purified NogoA-(567-748) protein; Line 8, protein molecular weight markers. (b) 
Coomasie brilliant blue stained SDS-PAGE gel showing the expression and affinity-
purification of the Nogo-66 protein under denaturing conditions. Line 1: total cell 
extract before IPTG induction; Lane 2: total cell extract after 0.5 mM IPTG induction 
at 20º C overnight; Line 3: Ni-agrose beads with bound Nogo-66; Line 4: Elution 1 
under the denaturing condition (in the presence of 8 M urea); Line 5: Elution 2 under 
the denaturing condition (in the presence of 8 M urea); Line 6: Elution 3 under the 
denaturing condition (in the presence of 8 M urea);  Line 7: Elution 4 under the 
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    The structural properties of Nogo-A-(567-748) were first investigated by CD 
spectroscopy. As shown in Figure 3.1.3a, the CD spectrum of Nogo-A-(567-748) in 
aqueous buffer had a maximal negative peak at ~202 nm and had no significant 
positive signal at 198 nm. In addition, there existed the negative shoulder signal at 
~225 nm. All of these indicated that Nogo-A-(567-748) was neither fully-structured 
nor assuming a “random coil” structure (Venyaminov & Yang , 1996) and it could be 
partially structured. To explore whether Nogo-A-(567-748) had any specific 
interaction with metal ions, we utilized CD measurements to monitor conformational 
changes induced by the addition of metal ions, including Ca2+, Mg2+，Cu2+, Ni2+ and 
Zn2+. The significant conformational change of Nogo-A-(567-748) was specifically 
induced by Zn2+. As shown in Figure 3.1.3a, the CD spectrum of Nogo-A-(567-748) 
showed dual negative signals at ~206 and 221 nm in the presence of 4 mM Zn2+, 
indicating a typical helical conformation. The results indicated that Zn2+ could 
specifically induce, to a significant degree, the polypeptide to assume a helical 
sturcture. 
The structural properties of the Nogo-A-(567-748) were further assessed by the 
NMR HSQC experiment, which is a sensitive probe to both secondary structures and 
tertiary packing. As shown in Figure 3.1.3b, 1H-15N NMR HSQC spectra of Nogo-A-
(567-748) showed very narrow spectral dispersions over both dimensions (~1 ppm 
over 1H and ~10ppm over 15N dimensions), indicating that Nogo-A-(567-748) did not 
have a tight side-chain packing. In particular, the number of the observed NMR cross 
peaks were only about 35, much less than those expected for an 182-residue protein, 





Figure 3.1.3. CD and NMR characterization of NogoA-(567-748) (a) Far-UV CD 
spectra of Nogo-A-(567-748) collected at 20 ℃ in a phosphate buffer at pH 6.5 (black 
tracing) and in a Tris-HCl buffer at pH 6.5 containing 4 mM zinc ion (grey tracing). (b) 
1H-15N HSQC spectrum of Nogo-A-(567-748) collected at 20 ℃ in a phosphate buffer 







protein. Usually, slow conformational exchange would result in significant line 
broadening for HSQC peaks and make these peaks undetectable. The manifested 
HSQC peaks in Figure 3.1.3b most likely resulted from the unstructured and flexible 
regions of the Nogo-A-(567-748), while the peaks for the regions undergoing slow 
conformational changes were undetectable. Consistent to the CD result, the HSQC 
spectrum above indicated that Nogo-A-(567-748) was partially-structured, probably 
with some properties characteristic of molten globule states (Song et al., 1998). 
Interestingly, upon addition of 4 mM Zn2+, no new HSQC peaks came up but the 
intensities of the existing peaks became stronger (spectrum not shown). This 
observation suggests that although the introduction of Zn2+ was able to significantly 
enhance the helical structure of Nogo-A-(567-748) as detected by CD, it was not 
sufficient to make the tertiary packing as tight as those found in a well-structured 
protein. 
 
3.1.2. CD and NMR characterization of Nogo-40 
The high insolubility of Nogo-66 in both aqueous buffer and a TFE/H2O mixture 
made it impossible to acquire 1H-15N HSQC spectrum of Nogo-66. We therefore 
focused our NMR structure determination on Nogo-40, which has been shown 
previously to be an excellent NgR antagonist by virtue of its ability to interact with 
NgR without eliciting downstream inhibitory signaling (Oertle  et al., 2003). 
Secondary structure prediction suggested that Nogo-40 had a strong propensity 
to form a helical structure (Figure 3.1.4). However, the preliminary CD and NMR 
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Figure 3.1.4. Secondary structure prediction of Nogo-40 by DNAMAN 
 











The severe peak overlap resulted in the failure of the NMR spectra assignment of 
Nogo-40 under these conditions. To gain insight into the intrinsic secondary structure 
preference of Nogo-40 experimentally, we dissected Nogo-40 into two fragments, 
namely the N- and C-terminal parts. Nogo-24, comprising of the N-terminal 24 
residues of Nogo-66, was successfully synthesized; while the systemization of the C-
terminal part of Nogo-40 failed. The sequential assignment of Nogo-24 was 
successfully achieved and the chemical shifts were presented in Table 3.1.1. The NOE 
assignment shown in Figure 3.1.5 clearly indicated that sequential NH-NH NOE 
connectivities existed over many residues of Nogo-24, strongly indicating intrinsic 
helix-forming propensity in the Nogo-24 peptide, even in aqueous buffer. This 
observation, together with the secondary structure predictions for Nogo-40, prompted 
us to conduct further NMR studies of Nogo-40 in the presence of the TFE which is 
well-known for its ability to stabilize intrinsic helixes.       
          Figure 3.1.6a shows the CD spectra of Nogo-40 in aqueous buffer and 
methanol/H2O mixtures. Nogo-40 had no stable conformation in aqueous buffer, with 
a negative peak at ~198 nm (Venyaminov et al., 1996). Interestingly, with the 
introduction of methanol, the CD spectra of Nogo-40 undergo dramatic changes. The 
CD spectra of Nogo-40 in the presence of methanol at a concentration of 74 % or 
above show one positive peak at ~198 nm and two negative peaks at ~208 and 222 nm 
respectively. This observation indicates that Nogo-40 adopts a well-formed helical 
conformation in the presence of 74 % or higher percentages of methanol. Similarly, 










Figure 3.1.5. NMR characterization of Nogo-24  NH-NH region of a NOESY 
spectrum of Nogo-24 (mixing time of 250 ms) acquired in an aqueous buffer (50 mM 











                                                                      1H (ppm) 
 
Figure 3.1.6. CD and NMR characterization of Nogo-40 (a) Far-UV CD spectra of 
Nogo-40 collected at 20 ºC in the presence of methanol at different concentrations; 
black: 50 mM phosphate buffer (pH 6.5), pink: 20 %, green: 36 %, Cyan: 49 %, dark 
violet: 60 %, brown: 68 %, dark green: 74 % and blue: 80 % (b) Far-UV CD spectra of 
Nogo-40 collected at 20 °C in the presence of TFE at different concentrations; black: 
50 mM phosphate buffer (pH 6.5); pink: 20 % TFE solution; green: 36 % and Cyan: 
49 %; red: 60 %. (c) NH-aliphatic region of a NOESY spectrum (mixing time of 250 
ms) of Nogo-40 acquired in a 50 mM phosphate buffer (pH 6.5) at 15 ºC. (d) NH-
aliphatic region of a NOESY spectrum of Nogo-40 (mixing time of 250 ms) acquired 
in a 50:50 (v/v) TFE/H2O mixture at 35 ºC. 
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It appears that 50 % TFE is sufficient to stabilize a full helical conformation for the 
peptide. 
         NMR spectroscopy was further utilized to explore the structural properties of 
Nogo-40. The very narrow resonance dispersion of amide protons (~0.7 ppm) and the 
lack of the side-chain packing with aromatic ring protons in aqueous buffer (Figure 
3.1.6c) demonstrated that Nogo-40 in aqueous buffer had no stable structure, which is 
consistent with the CD results above. In contrast, the same NOESY region of Nogo-40 
in the 50:50 (v/v) TFE/H2O mixture (Figure 3.1.6d) shows a dramatically increased 
dispersion of amide protons (~1.5 ppm) and extensive side-chain packing with 
aromatic ring protons, indicating that Nogo-40 adopts a well-formed helical structure 
in the presence of 50 % TFE. 
 
3.1.3. NMR structure determination of Nogo-40 
         Based on the preliminary structure characterization, the structure determination 
of Nogo-40 by NMR spectroscopy was thus carried out in a 50:50 (v/v) TFE/H2O 
mixture. Figure3.1.7 presents a NH-αH region of NOESY spectrum of Nogo-40 with 
sequential assignments labeled. The chemical shifts associated with Nogo-40 are listed 
in Table3.1.2. The αH conformational shifts (Figure 3.1.8a) suggested that Nogo-40 in 
50 % TEF contained two helical fragments, one at the N-terminal part and the other 
over the C-terminus. Actually, the helical conformational shifts already existed for 
Nogo-24 in aqueous buffer (Figure 3.1.8a), although less profound than those for 
Nogo-40 in 50 % TEF. The medium-range NOE connectivities such as dαN(i, i+2), 
dαN(i, i+3) and dαβ(i, i+3) used for identification of secondary structures again  
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Figure 3.1.7. NMR spectral assignment of Nogo-40 The NH-αH region of a NOESY 
spectrum of Nogo-40 (mixing time of 250 ms) acquired in a 50:50 (v/v) TFE/H2O 
mixture at 35℃with sequential assignments indicated. Several medium -range NOEs 
defining helical structures are labeled. 
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Figure 3.1.8. Secondary structures of Nogo-24 and Nogo-40 
(a) Cα proton conformational shifts of Nogo-24 (in grey) and Nogo-40 (in black). 






supported the existence of the two helical segments in Nogo-40 (Figure 3.1.8b).           
       Fifty Nogo-40 structures were calculated from NMR restraints with a simulated 
annealing protocol implemented by the CNS program. The restraints included in 
structure calculation are presented in table 3.1.3. Out of these, ten lowest-energy 
structures with a distance violation of less than 0.3 Ǻ and a dihedral angle violation of 
less than 5 degree were selected for further analysis. The structural statistics for the ten 
selected structures were also included in Table 3.1.3. The low values of distance and 
dihedral angle energies indicate that all selected structures satisfy the experimental 
NMR constraints. Moreover, the covalent geometry is well respected as demonstrated 
by the low RMS deviation values for the bond lengths (0.0019 Ǻ) and the valence 
angles (0.4 degree). 
          All ten structures of Nogo-40 contain two helices, one over residues 7 to 12 and 
another over residues 26 to 37. Superimposition of the 10 structures over either helices 
(Figure3.1.9a, b) gives low RMS deviation values (Table3.1.3), indicating that both 
helices are well defined. However, due to the absence of NOEs between N-and C-
terminal helices, their relative orientation cannot be determined. A more detailed 
examination of the ten selected structures shows that there are two populations among 
the ten structures. Five of these structures, as represented in Figure 3.1.9c, contain 
only two helices (one from residues 7 to 12 and another from 26 to 37). However, 
another set of five structures, as represented in Figure 3.1.9d, has an additional helix 
over residues 20 to 24. Indeed, conformational shifts shown in Figure3.1.8a and 
medium-range NOEs in Figure3.1.8b do indicate a helical conformation over residues 






Restrains for structure determination 
NOE distance constraints                                                198 
        Sequential                                                                122 
      Medium range (│i-j│≤4)                                            76 
 
      Statistics for structure calculation 
Final energies (kcal mol -1)                                          
E (total)                                                                           63.5±6.6    
E (bond)                                                                          2.3±0.3 
E (angle)                                                                          28.5±1.9 
E (improper)                                                                    4.2±1.1 
E (VdW)                                                                          21.0±2.5 
E (NOE)                                                                          7.3±2.5 
 
RMS deviations from idealized geometry 
Bond (Å)                                                                     0.002±0.0001 
Angle (degree)                                                             0.400±0.0135 
Improper (degree)                                                        0.285±0.0350 




Average RMSD (Å) from the lowest-energy structure for backbone/heavy actoms 
Whole (2-39)                                                                       3.00/4.00 
N-terminal helix (7-12)                                                       0.22/1.11 
C-terminal helix (26-37)                                                     0.61/1.58 




Table 3.1.3. NMR restrains used for structure calculation and structure statistics 




Figure 3.1.9. Solution structure of Nogo-40 
(a)The ten lowest-energy structures superimposed over the N-terminal helix over 
residues 7-12. (b)The same ten lowest-energy structures superimposed over the 
Cterminal helix over residues 26-37. (c) Ribbon representation of one conformational 
ensemble of Nogo-40 structure with only two helices formed.  (d) Ribbon 
representation of another conformational ensemble of Nogo-40 structure with an 
additional helix over residues 20 to 24.  (e) Representation of the electrostatic 
potential associated with the contact surface of the Nogo-40 solution structure. Two 
distinctive surfaces are observed: N-terminal surface is largely positive (blue) while 






side-chain NOEs among residues His17, Phe19, Tyr22 and Leu23, the helix over 
residue 20 to 25 is distorted to some extent and consequently became undetectable in 
five of the ten selected structures. Figure3.1.9e presents a representation of the 
electrostatic potential associated with the contact surface of the Nogo-40 structure. 
The most interesting observation here is that the N- and C-terminal parts of Nogo-40 
have opposite electrostatic potential surfaces. More specifically, the N-terminal 9 
residues of Nogo-40 constitute a large positive surface (blue) while the C-terminal 
residues make up a large negative surface (red). 
 
3.1.4. Discussion  
The molecular interaction between Nogo-66 and NgR poses inhibitory effects 
on the CNS neuronal regeneration; therefore the Nogo-66-NgR interface is an 
extremely-promising target for design of molecules to treat CNS injuries. A recent 
study showed that Nogo-A, the longest member of the Nogo transcripts encoding for 
1192 amino acid residues, had at least two discrete regions with neuronal growth 
inhibitory effects. Since the structural characterization of Nogo-A is poorly understood, 
we carried out a detailed CD and NMR investigation in attempts to gain structurally 
insights into these two functional regions. Our results revealed that although Nogo-A-
(567-748) is functionally active, it is only partially-structured. It is possible that once 
binding to interacting partners or cognate receptors, the Nogo-A-(567-748) could 
become well structured. Interestingly, the observation that the Zn2+ was able to 
specifically induce the formation of helical structures in Nogo-A-(567-748) might 
constitute an interesting clue for future functional studies of Nogo-A.  
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The recent identification of Nogo-40 as a potent NogoR antagonist indicates 
that Nogo-40 may represent a promising starting-point for the design of potential 
therapeutic agents to enhance CNS neuronal regeneration. Knowledge of the three-
dimensional structure of Nogo-40 is essential both for understanding the endogenous 
Nogo-66-NgR interaction and for the design of other NgR-binding antagonists. 
Although Nogo-40 is highly disordered in aqueous buffer, close NMR examination 
indicated that it has an intrinsic propensity to assume helical conformations. This 
provided a key rationale for us to utilize helices stabilizing solvent TFE to continue 
the NMR structural determination of Nogo-40 (Song  et al., 2001). 
The electrostatic potential surface plays a critical role in controlling the affinity 
and specificity of protein–protein interactions. Recently, the determination of the 
crystallographic structure of the NgR ectodomain led to the speculation that one 
potential Nogo-66 binding site on NgR has characteristics of a negative cavity, 
consisting of residues Asp111, Asp114, Ser113 and Asp138 (Barton et al. 2003; He et 
al. 2003; Schimmele and Pluckthun, 2005). However, due to the lack of the structure 
of the Nogo extracellular domain, the possible positively charged Nogo patches for 
NgR binding remained previously unassigned. The NMR structure of Nogo-40 reveals 
that the N- and C-terminal segments of Nogo-40 have opposite electrostatic potential 
surfaces, thus providing an important clue for understanding the Nogo-40-NgR 
interaction. As shown in Figure 3.1.9e, the C-terminal part of Nogo-40 is highly 
negatively charged, making it unlikely as a candidate for binding to this acidic NgR 
cavity. On the other hand, it is highly probable that the N-terminal positive part is 
responsible for its binding to the NgR negative cavity. This in complete agreement 
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with previous finding that deletion of the first five residues at the N-terminal end of 
Nogo-66 greatly diminished NgR binding, and the deletion of the first ten residues 
abolished NgR binding. Previously functional study also showed that residues 30-33 
of Nogo-66 (containing residues Glu31 and Glu32) are important for NgR binding. It 
is reasonable to speculate that the negative C-terminus of Nogo-40 may bind to a 
positively charged surface on NgR; alternatively, it is also possible that the C-terminus 
of Nogo-40 will even bind to other molecules such as NgR co-receptor p75NTR in the 
formation of a multi-component complex. 
In summary, the first stage of our study represents the first structural insights 
into the two functional regions of Nogo-A critical for inhibiting CNS neuronal 
regeneration. The results showed that the region consisting of Nogo-A-(567-748) is 
only partially structured but can be induced to form a helical structure via interaction 
with Zn2+. Furthermore, the determination of the Nogo-40 solution structure offers a 
starting point for further understanding the interaction between NgR and Nogo-40, and 
future designs of molecules to enhance CNS neuronal regeneration using NMR 


































3.2.    Solution Structure of Nogo-60 and Design 
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  Very surprisingly, later we found that a series of buffer-insoluble protein domains 
including Nogo-66 fragments can be easily solubilized in salt-free water to a high 
concentration. This discovery therefore allowed us to go back to determine the 
structure of Nogo-60 (residues 1055-1114) in aqueous solution and further designed 
Nogo-54 based on the analysis of Nogo-60 3D structure.  
 
3.2.1. Preliminary structural characterization 
Four Nogo peptides, including Nogo-66, Nogo-40, Nogo-60 and Nogo21-60, 
were characterized by CD (Fig3.2.1a). CD results indicated that Nogo-40 owned no 
stable secondary structure in water, similar to that in the buffer (Li et al. 2004). Nogo-
(21–60), Nogo-60, and Nogo-66 were only soluble in water and showed far-UV CD 
spectra for a helical conformation. Most importantly, Nogo-(21–60) and Nogo-60 also 
had well-separated HSQC spectra (spectra not shown), recommending their suitability 
for further NMR structure determination. Strikingly, although Nogo-66 was soluble in 
water and   had concentration-independent CD spectra, the majority of its HSQC 
peaks were invisible even at a low peptide concentration of 50 μM (spectra not shown). 
This observation implied that the last six residues might be unstructured, and their 
inclusion would dramatically provoke conformational exchanges of Nogo-66 on 
micro- to millisecond timescales, thus leading to a significant NMR line-broadening. 
This phenomenon is analogous to previous discovery that a slight perturbation on a 
small protein CHABII resulted in an extensive disappearance of NMR resonance 
peaks, although the secondary structure and tertiary topology remained highly native-
like (Wei and Song, 2005). 
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3.2.2. Structure and 15N backbone dynamics of Nogo-60 
 
            The reasonable good behavior of Nogo-60 in water (pH4.0) made it possible to 
determine Nogo-60 3D structure by NMR. Table 3.2.1 presents the assigned chemical 
shifts of Nogo-60 atoms. As seen in Figure3.2.1b, an extensive existence of sequential, 
in particular (i, i + 2) NH–NH NOEs strongly revealed that Nogo-60 assumed a well-
formed helical structure in water (Wagner and Wuthrich, 1982). To deal with the 
problem of severe resonance overlaps in proton NMR spectra, Nogo-60 was 
subsequently studied by heteronuclear NMR spectroscopy. Figure3.2.1c presents an 
assigned HSQC spectrum, and Figure3.2.2 summarizes NOE connectivities critical for 
defining secondary structures. Based on characteristic NOEs patterns including dNN(i, 
i + 2), dαN(i, i +3), and dαN(i, i + 4), as well as αH conformational shifts (data not 
shown), it was very clear that Nogo-60 had a well-formed helical structure constituted 
by three helical segments. 
The NMR structure of Nogo-60 was calculated from the experimental NMR 
constraints using the  CYANA program. (Guntert, 2004). Table 3.2.2 summaries the 
constraints used and structural statistics for the twenty accepted structures. 
Interestingly, Nogo-60 adopted a very unusual helical structure composed of three 
well-formed α-helices spanning over residues 6–15, 21–40, and 45–53, followed by 
the unstructured residues 55–60 (Fig.3.2.3a,b). Due to the lack of any long-range NOE 
between the first helix and the rest of the molecule, the orientation of the first helix 







      Figure 3.2.1. CD and NMR characterization of Nogo peptides 
(a) Far-UV CD spectra of Nogo-(21–60) (pink), Nogo-60 (blue), Nogo-66 (green), and 
Nogo-40 (black) were collected in the salt-free water (pH 4.0) at 293 K. The far-UV 
CD spectrum of Nogo-54 (cyan) was acquired in 10 mM phosphate buffer (pH 5.4). (b) 
The NH-NH region of a two-dimensional 1H NMR spectrum of Nogo-60 in the salt-
free water (pH 4.0) at 278 K. Some dNN(i, i + 2) NOEs are indicated, and labels of 
some long-range dNN NOEs are boldface. (c) The 1H–15N heteronuclear HSQC 
spectrum of the 15N-labeled Nogo-60 in the salt-free water (pH 4.0) at 278 K, with 












Figure 3.2.2. The NOE patterns critical for defining the secondary structure of 














residues N NH Hα Hβ HR Other 
R1 122.879 8.511 4.275 1.690; 
1.515 
1.439 3.076 
I2 122.227 8.222 4.112 1.689 0.751 1.354, 1.037 
Y3 126.367 8.547 4.518 2.870  7.00, 6.51 
K4 125.031 8.472 4.123 1.723, 
1.576 
 1.202 
G5 126.648 7.846 3.802    
V6 119.758 8.055 4.074 1.978  0.866 
I7 126.297 8.459 4.074 1.750 0.777 0.810 
Q8 125.875 8.591 4.257 1.985, 
1.866 
2.288  
A9 126.227 8.466 4.240 1.296   
I10 121.023 8.274 4.005 1.735 0.798 1.416, 1.302 
Q11 125.242 8.567 4.260 2.006 2.293  
K12 123.766 8.559 4.015 1.886, 
1.758 
1.702  
S13 116.945 8.485 4.356 3.813   
D14 121.867 8.453 4.598 2.699   
E15 120.813 8.365 4.142 2.021, 
1.905 
2.307  
G16 126.508 8.490 3.793    
H17 117.719 8.163 4.925 3.124, 
3.040 
 7.24 
P18       
F19 121.164 8.570 4.49 3.062, 
2.980 
 7.18, 7.15 
R20 123.836 8.097 4.124 1.576, 
1.422 
  
A21 125.009 8.242 4.106 1.269   
Y22 119.265 8.113 4.423 2.916  7.015，6．73 
L23 123.466 8.143 4.189 1.486, 
1.418 
 0.802 
E24 121.305 8.359 4.141 2.025, 
1.934 
2.342  
S25 116.031 8.272 4.318 3.893, 
3.841 
  
E26 121.938 8.336 4.223 2.020, 
1.936 
2.325  
V27 120.742 8.055 3.919 1.953 0.878  
A28 126.411 8.258 4.200 1.34   
I29 120.039 8.152 3.975 1.781 0.881 1.468, 1.104 
S30 118.492 8.253 4.284 3.954, 
3.816 
  
E31 122.148 8.427 4.181 2.007   
E32 120.039 8.244 4.177 2.013 2.360  
L33 121.867 8.075 4.210 1.699,  0.847 
82 
1.599 
V34 120.391 7.977 3.852 2.018 0.891  
Q35 122.570 8.300 4.161 2.005, 
1.943 
2.290  





Y37 119.547 8.200 4.540 3.041, 
2.861 
 7.05，6．72 
S38 116.805 8.203 4.320 3.798   
N39 120.461 8.400 4.638 2.780   
S40 116.453 8.312 4.326 3.840   
A41 125.449 8.337 4.230 1.340   
L42 119.688 8.058 4.219 1.565, 
1.467 
1.345 0.984 
G43 126.438 8.257 3.800    
H44 117.859 8.299 4.658 3.197, 
3.100 
 7.21 
V45 121.445 8.228 4.046 1.965 0.854  
N46 122.570 8.718 4.671 2.788, 
2.705 
  
C47 120.180 8.424 4.543 2.826, 
2.733 
  
T48 116.453 8.386 4.289 1.163   
I49 122.852 8.334 3.989 1.783 0.835 1.164 





E51 121.023 8.146 4.180 2.275, 
1.979 
  
L52 122.781 8.326 4.167 1.596, 
1.466 
  
R53 120.390 8.302 4.134 1.735, 
1.636 
1.486 3.073 
R54 121.523 8.108 4.138 1.483, 
1.272 
  
L55 121.023 8.044 4.124 1.516, 
1.484 
 0.802 
F56 119.125 8.088 4.531 2.977, 
2.916 
 7.18, 7.15 
L57 122.289 8.108 4.313 1.591, 
1.478 
 0.806 
V58 119.898 8.034 4.042 1.978  0.767 
D59 123.344 8.484 4.670 2.770, 
2.618 
  
D60 124.328 8.043 4.425 2.698   
 












NOE upper distance limits 
                Intra-residue                                                                   191 
                Sequential                                                                       214 
                Medium range                                                                171 
                Long range                                                                      18 
                Total                                                                               594 
 
Dihedral angle restrains                                                                86 
 
 
20 Final CYANA structures 
              CYANA target function                                              0.52±0.13 Å 
              Distance restraint violations (›0.20Å)                                 0 
              Angle restraint violations (›5º)                                            0 
 
 
Ramachandran analysis  
               Residues in most favored regions                                 79.6 % 
               Residues in additional allowed regions                         13 % 
               Residues in generously allowed regions                       5.6 % 
               Residues in disallowed regions                                     1.9 % 
 
 
Root mean square deviation (Å) 
                Residues 5-15 (the first helix)                               1.38 (all atoms) 
                                                                                               0.44 (backbone atoms) 
                Residues 21-40; 45-53                                           1.53 (all atoms) 





Table 3.2.2. NMR constraints and structural statistics for the 20 accepted       
















       
Figure 3.2.3. Solution structure of Nogo-60 (pdb code 2g31) 
(a) The solution structure of Nogo-60 in the ribbon mode. (b) All 20 accepted Nogo-
60 structures superimposed over residues 21–40 and 45–53. The electrostatic potential 
surface of Nogo-60 with a molecular orientation the same as Figure 3.2.3a (c) and 
with a 180° rotation of Figure 3.2.3c around the Z-axis. (d) Positively charged patches 







separately, the first helix itself as well as the rest of the molecule was well defined. 
Very interestingly, the last helix had long-range packing with the C-half of the middle 
helix, as clearly evident from experimental long range NOEs (Fig.3.2.2). This packing 
appeared to be a prerequisite for the whole Nogo-60 molecule to form the helical 
structure because Nogo-40 with the last helix truncated had no stable secondary 
structure again in water.  
           15N NMR backbone relaxation data provide valuable information for the 
dynamics of the local environment of a protein on the pico- to nanosecond timescale. 
In particular, {1H}–15N heteronuclear steady-state NOE (hNOE) provides a measure to 
the backbone flexibility. As seen in Figure3.2.4c, many Nogo-60 residues had hNOE 
values >0.6, indicating that the regions around these residues have significantly 
reduced backbone motions (Kay et al. 1989; Clore et al. 1990; Farrow et al. 1994). 
Moreover, as shown in Figure3.2.4b, a large portion of the Nogo-60 residues had T2 
values >100 msec, implying that no significant aggregation was present at this peptide 
concentration in salt-free water. 
 
3.2.3. Design of structured and active Nogo-54 
          A more detailed examination of the structure of Nogo-60 revealed two 
interesting observation. Firstly, in addition to the positively charged patches previously 
spotted in Nogo-40 (Li et al. 2004), three additional ones were identified uniquely for 
Nogo-60 (Fig 3.2.3c, d). These spots could be the candidates for the binding to NgR. 
Secondly, the C-terminal six residues, namely, Leu55–Phe56–Leu57–Val58–Asp59– 
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Figure 3.2.4. 15N NMR backbone dynamics.  The 15N NMR backbone relaxation 
data of Nogo-60 in the salt-free water (pH 4.0) at 278 K on an 800-MHz Bruker 
Avance NMR spectrometer. (a) 15N T1 (longitudinal) relaxation times, (b) 15N T2 
(transverse) relaxation times, and (c) {1H}–15N steady-state NOE intensities. The bars 



















Figure3.2.5. Solution structure of Nogo-54  (a) The solution structure of Nogo-54 in 
the ribbon mode. (b) All 20 accepted Nogo-54 structures superimposed over residues 





















NOE upper distance limits 
                Intra-residue                                                                   360 
                Sequential                                                                       244 
                Medium range                                                                224 
                Long range                                                                      5 
                Total                                                                               833 
 
Dihedral angle restrains                                                                78 
 
 
20 Final CYANA structures 
              CYANA target function                                              2.05±0.37Å 
              Distance restraint violations (›0.20Å)                                 0 
              Angle restraint violations (›5º)                                            0 
 
 
Ramachandran analysis  
               Residues in most favored regions                                 85.4 % 
               Residues in additional allowed regions                         8.3%  
               Residues in generously allowed regions                       4.2 % 
               Residues in disallowed regions                                     2.1 % 
 
 
Root mean square deviation (Å) 
                Residues 8-15 (the first helix)                               0.306(backbone atoms) 
                Residues 21-40 (the secondary helix)                   0.590 (backbone atoms) 
                Residues 21-40 (the third helix)                           0.399 (backbone atoms) 
 
                
 
   Table3.2.3. NMR constraints and structural statistics for the 20 accepted       








Asp60, adopted no regular secondary structure but constituted an exposed 
hydrophobic patch in Nogo-60. We thus reasoned that this patch might contribute to 
the high insolubility of Nogo-60, which precipitated even with an addition of 0.2 mM 
sodium chloride. Therefore, we designed Nogo-54 by removing the six residues, and 
suddenly Nogo-54 became buffer-soluble. The buffer soluble Nogo-54 was further 
characterized by CD and NMR.  Nogo-54 had very similar CD spectra characteristic 
of a helical conformation in both water and buffer (Figure 3.2.1a). HSQC spectra of 
Nogo-54 in the buffer and in water were almost superimposable (spectra not shown), 
indicating that the salt had no significant effect on its conformation. To further model 
the 3D structure of Nogo-54, CYANA was used with an input of 78 dihedral angles 
and 833 upper distance limits.  As expected, the structure of Nogo-54 was almost 
similar to Nogo-60, containing three helices and with the long-rang packing between 
the C-half of the middle helix and the last helix (Figure 3.2.5).  
             Neurite outgrowth-inhibiting ability of Nogo-54 was assessed by neurite 
outgrowth assay (Figure 3.2.6). Soluble His-Nogo-54 fusion protein has observable 
inhibition effect on the neurite outgrowth from the dose of 15μg. With the increasing 
of the dose of Nogo-54, the inhibition effect significantly increased; while the control 
of His-tag and Nogo-40 do not possess the inhibitory ability even at high dose (45 μg). 
This study demonstrates that Nogo-54 can mimic the full Nogo 66 to interact with 
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Figure 3.2.6. Effects of Nogo-54 on neurite outgrowth from murine cerebellar 
neurons Neurons were separated from postnal 6 days murine cerebellum. After 
seeding for 1 hour, different concentration Nogo-54 were added in the cells culture 
wells. Then cells were incubated for 26 hours, fixed, and stained with coomassie 
brilliant blue. The neurite length was measured and compared. His-tag is control.  







3.2.4. Discussion  
Previously we determined the NMR structure of Nogo-40 in the presence of 50 % 
TFE. However, based on the Nogo-40 structure, it is still not well understood why  
Nogo-40 owned a relatively weak NgR-binding affinity, and as such, the rationale for 
further optimization is elusive.  In the present study, the first successful determination 
of the Nogo-60 structure in aqueous solution provides important insight into this issue 
and implies that the weak affinity of Nogo-40 might largely result from the absence of 
the stable helical structure and/or some binding-important patches. The long-range 
packing between the last helix and the C-half of the middle helix is essential to 
stabilize the helical structure of the molecule. It makes sense that this packing shielded 
the middle helix from being highly exposed to the bulk water, thus stabilizing the 
intrinsic helix-forming propensity of the whole molecule. In contrast, the absence of 
the packing in Nogo-40 might result in a severe solvation of the middle helix, thus 
destabilizing the helix formation.  
 The availability of the Nogo-60 structure also offered us rationales for the 
successful design of the structured and buffer-soluble Nogo-54. Because Nogo-54 was 
helically structured and carried additional positively charged candidate spots for NgR-
binding, we thus proposed that Nogo-54 might be used as a novel NgR antagonist as 
well as serve as a promising starting point for further design of therapeutics to enhance 














         
      3.3.   Structural Characterization of the Human Nogo-B  















         We extended the structural study to the full-length of NogoA/B. Besides the 
two transmembrane domains and the extracellular loop Nogo-66, we characterized the 
whole NogoB structure, including the N-terminus of 200 residues and the C-tail ER 
motif of 38 residues. We also systematically dissected the whole Nogo-A N-terminus 
for structural study (Figure3.3.1). Bioinformatics analysis, Circular dichroism (CD) 
and NMR spectroscopy were used to take insight into the structural characterization of 
NogoA/B.  
 
3.3.1. Bioinformatics analysis of Nogo-B 
 
In an attempt to facilitate experimental investigations, the whole Nogo-B 
molecule was first assessed by a variety of bioinformatics tools to predict secondary 
structure, ordered/disordered regions as well as to pinpoint functional binding sites. 
The secondary structure prediction by PSIPRED indicated that the 200-residue N-
terminus of Nogo-B had very a low secondary structure preference. Furthermore, the 
result from disordered predicators GlobPlotTM, IUPred, VSL2B which measures the 
sequence complexity and intrinsic disordered region, all suggested that the majority of 
the Nogo-B N-terminus was of low complexity and consequently might be highly 
unstructured (Figure 3.3.2b). We also did the prediction for other human RTNs. 
Similarly, except the RHD region, the N-terminuses of RTNs are all highly disordered 
(appendix I).  
On the other hand, examination of the amino acid sequence revealed that the 373-
residue Nogo-B molecule contained 48 proline residues out of which 41 were enriched 







                              
 
Figure 3.3.1. The domain organization and dissection of the human Nogo proteins 
Three Nogo splice variants, Nogo-A/B/C share a conserved C-terminal 
reticulonhomolog domain (RHD) consisting of two short transmembrane fragments, 
an extracellular loop Nogo-66 and a short C-terminal tail carrying an endoplasmic 
reticulum (ER) retention motif. Nogo-A has an 1016-residue N-terminus with the first 
200 residues almost identical to the Nogo-B N-terminus while Nogo-C has a very 
short N-terminus. In this study, the 1016-residue N-terminal sequence of the human 
Nogo-A was dissected into Nogo-A (1-200) (designated as P0 which is an equivalent 
of Nogo-B (1-200)) and two groups of eight overlapped fragments (designated as P1-











Figure 3.3.2. Analysis of globularity and disordered regions of Nogo proteins 
The globularity and disordered regions were assessed by bioinformatics tool VSL2B 
(http://www.ist.temple.edu/disprot/predictorVSL2.php). (a) Output profile for the 
entire Nogo-C protein. The unique Nogo-C N-terminus and conserved C-tail are all 
predicted to be highly-disordered. On the other hand, the two transmembrane 
fragments are estimated to be well-structured. (b) Output profile for the N-terminus 
(residues 1-200) of Nogo-B which was predicted to be highly-disordered. (c) Output 
profile for the N-terminus (residues 1-1016) of Nogo-A. Most regions additional to the 
first 200 residues which is an equivalent of the Nogo-B N-terminus are also predicted 



















with the lack of a defined structure (Dunker AK et al., 2001; Romero P et al., 2001 
and Tompa Peter, 2002). However, from a functional standpoint, proline rich 
sequences usually constitute linear binding motifs particularly for SH3 and WW 
modular domains. Therefore it is not surprising that many short binding motifs were 
spotted out by eukaryotic linear motif (ELM) resource (Figure 3.3.3). Indeed, the 
Nck2 SH3 domain was demonstrated to bind a short Nogo-B region at a high affinity 
(Liu et al., 2006). 
 
3.3.2. CD and NMR characterization of N- and C-termini of Nogo-B 
To experimentally assess the structural property of Nogo-B, we first cloned and 
expressed the entire N-terminus Nogo-B (1-200) as well as Nogo-33, the 33-residue 
C-tail with only the ER retention motif deleted. Unfortunately, we found that the first 
31 residues were subject to cellular proteolysis which made it very difficult to obtain 
the entire Nogo-B (1-200). This observation suggests that Nogo-B is highly disordered 
because disordered proteins have been extensively found to be very sensitive to 
proteolytic digestion (Fontana et al., 1997). Consequently, we further cloned Nogo-B 
(32-200) which turned out to give rise to a high expression yield. 
As seen in Figure 3.3.4a, Nogo-B (1-200) and Nogo-B (32-200) owned very 
similar far-UV CD spectra with a negative signal at ~198 nm and without any positive 
signal at ~190 nm. This observation clearly indicated that both Nogo-B (1-200) and 
Nogo-B (32-200) were lacking predominant secondary structures in solution and 
removal of the first 31 residues had no significant structural consequence. Therefore, 





reflects secondary structure features, near-UV CD is very sensitive to the overall 
tertiary packing of a protein (Uversky, 2002). The near-UV CD spectra of Nogo-B 
(32-200) were recorded in the absence and presence of 8 M denaturant urea (Figure 
3.3.4b). The high similarity between two near-UV spectra suggested that the N-
terminus of Nogo-B had no tight tertiary packing even under the native condition. 
Completely consistent with CD results, 1H-15N NMR HSQC spectra of both Nogo-B 
(1-200) and Nogo-B (32-200) were very similar, with very narrow spectral dispersions 
over both dimensions (~1 ppm over 1H and ~20 ppm over 15N dimensions) (Figure 
3.3.4c). Moreover, in presence of 8M urea, no significant change in the spectral 
dispersion and peak numbers were observed for 1H-15N NMR HSQC spectra of Nogo-
B (32-200) (Figure3.3.4d). These results provided the strongest evidence that both 
Nogo-B (1-200) and Nogo-B (32-200) were highly-disordered with no tight tertiary 
packing. In fact, in order to gain residue-specific knowledge, we prepared a 15N/13C 
double-labeled sample of Nogo-B (32-200) at ~1 mM protein concentration and 
collected a pair of triple-resonance NMR experiments HN(CO)CACB and 
CBCA(CO)NH. Unfortunately, we failed to achieve its sequential assignment due to 
significant HSQC peak overlap, resonance degeneration resulting from its low 
sequence complexity and lack of populated secondary and tertiary structures. In 
particular, there were some minor and weak peaks in the HSQC spectrum of this 
sample (spectrum not shown), which were attributed to result from cis-trans proline-
isomerization by examining three-dimensional NMR spectra HN(CO)CACB and 
CBCA(CO)NH. 






Figure 3.3.4.  CD and NMR characterization of the Nogo-B N-terminus (a) Far-
UV CD spectra of Nogo-B (1-200) (black) and Nogo-B (32-200) (grey) with a protein 
concentration of ~15 μM at 20 ℃in the 20 mM phosphate buffer (pH 6.8). (b) Near-
UV CD spectra of Nogo-B (32-200) in the absence (black) and presence (grey) of 8M 
urea with a protein concentration of ~150 μM at 20 ℃in the 20 mM phosphate buffer 
(pH 6.8). (c) 1H-15N NMR HSQC spectra of the 15N-labeled Nogo-B (1-200) (black) 
and Nogo-B (32-200) (red) with protein concentrations of ~500 μM at 20 ℃in the 50 
mM phosphate buffer (pH 6.8). (d) 1H-15N NMR HSQC spectrum of the 15N- labeled 
Nogo-B (32-200) in the absence (blue) and presence (red) of 8 M urea with protein 






packing property (Englander , 2000). When the 15N-labeled Nogo-B (32-200) was 
lyophilized and re-dissolved in 100% D2O, all HSQC peaks disappeared within the  
experimental dead time (spectrum not shown). This result again indicated that Nogo-B 
(32-200) was highly flexible in solution and all of its amide protons were openly-
accessible to the bulk solvent. Furthermore, we also measured NMR heteronuclear 15N 
NOE to assess the backbone dynamics of Nogo-B (32-200) (Farrow et al., 1997). 
Most hNOE values were very small (less than 0.3) or even negative, with an average 
value of ~0.28 (data not shown), typical of a highly-disordered protein. 
Similarly, Nogo-33 identical for all three Nogo proteins was predicated (Figure 
3.3.2a) and subsequently experimentally shown to be highly-disordered as judged 
from its far-UV CD (Figure 3.3.5a) and narrowly-dispersed HSQC spectrum (only ~ 
0.5 ppm over 1H and ~19 ppm over 15N dimensions) (Figure 3.3.5b). 
 As a result, it could be concluded that except for the two transmembrane 
fragments and extracellular loop Nogo-66 adopting a three-helix structure, other 
Nogo-B regions were highly-disordered. 
 
3.3.3. CD and NMR characterization of the dissected Nogo-A fragments 
 
 The obtained results that both N- and C-termini of Nogo-B were highly 
unstructured raised an interesting question regarding the structural property of the 
1016-residue N-terminus of Nogo-A. To address this, we first analyzed the Nogo-A-
specific residue over residues 201-1016 with the above-mentioned bioinformatics 
tools and the output result indicated that more than 70 % of the sequence was 





                 
Figure 3.3.5. CD and NMR characterization of the Nogo-33 (a) Far-UV CD 
spectrum of Nogo-33 with a protein concentration of ~15 μM at 20 ℃in the 20 mM 
phosphate buffer (pH 6.8). (b) 1H-15N NMR HSQC spectrum of the 15N-labeled 
Nogo-33 with a protein concentration of ~500 μM at 20 ℃in the 50 mM phosphate 










distributed in the ~816 residue Nogo-A-specific region (Figure3.3.2c).  Since the N-
terminus of Nogo-B is almost identical to the first 200 residues of Nogo-A, we thus 
cloned Nogo-A (201-1016) as both GST- and His-tag fused proteins. Unfortunately, no 
recombinant protein could be detected despite extensive optimization of the culture 
conditions, possibly due to its high sensitivity to cellular proteolytic degradation. 
Consequently, we dissected Nogo-A (201-1016) into two sets of overlapped fragments, 
with each set having four ~200 residue fragments as the size of autonomous protein 
folding domains usually ranges from120 to 200 residues (Peng  et al., 2000). The two 
sets of dissected Nogo-A fragments P1-P8 were successfully expressed and purified by 
HPLC. Very interestingly, the apparent molecular weights of all 8 fragments as 
estimated from SDS-PAGE were ~ 1.5 times larger than those calculated from their 
sequences. Moreover, the same phenomenon was observed for Nogo-B (1-200) , 
Nogo-B (32-200) and Nogo-A-(567-748).This observation could serve as an evidence 
that these Nogo fragments are intrinsically unstructured because previously this 
abnormal behavior on SDS-PAGE was proposed as an indicator of intrinsically 
unstructured proteins (Tompa , 2002). The relatively-slow mobility was attributed to 
their unusual amino acid composition and low capacity of SDS binding. 
  Figure 3.3.6 shows the far-UV CD and HSQC spectra of the first set of four 
fragments P1-P4 spanning over the Nogo-A residues 201-1016. Similar to those 
observed for Nogo-B, all four fragments had far-UV CD spectra typical of disordered 
proteins and their HSQC spectra showed sharp resonance peaks distributed within 
very narrow spectral dispersions. Therefore, the results indicated that this set of 





                
Figure 3.3.6. CD and NMR characterization of the first group of the dissected 
Nogo-A fragments (a) Far-UV CD spectra of the first group of the dissected Nogo-A 
fragments with a protein concentration of ~25 μM at 20 ℃in the 10 mM phosphate 
buffer (pH 6.8). Black solid curve: P1 (residues 201-408); grey solid curve: P2 
(residues 409-616); black dashed curve: P3 (residues 617-824); and black dotted curve: 
P4 (residues 825-1016). 1H-15N NMR HSQC spectra for the 15N-labeled P1 (b); P2 (c); 
P3 (d) and P4 (e) fragments with protein concentrations of ~500 μM at 20 ℃in the 50 









Figure 3.3.7. CD and NMR characterization of the second group of the dissected 
Nogo-A fragments (a) Far-UV CD spectra of the second group of the dissected Nogo-
A fragments with a protein concentration of ~25 μM at 20 ℃in the 10 mM phosphate 
buffer (pH 6.8). Black solid curve: P5 (residues 201-358); grey solid curve: P6 
(residues 359-566); black dashed curve: P7 (residues 567-774); and black dotted curve: 
P8 (residues 775-1016). 1H-15N NMR HSQC spectra in the absence (blue) and in the 
presence (red) of 8 M urea for the 15N-labeled P5 (b); P6 (c); P7 (d) and P8 (e) 
fragments with protein concentrations of ~500 μM at 20 ℃in the 50 mM phosphate 






















Figure 3.3.8. CD and NMR characterization of the mixture of nine dissected 
Nogo-A fragments P0-P9 (a) Far-UV CD spectrum of the mixture of nine dissected 
Nogo-A fragments P0-P8 at an equal molar ratio at 20 ℃ in the 10 mM phosphate 
buffer (pH 6.8). (b) 1H-15N NMR HSQC spectrum of the mixture of nine dissected 
Nogo-A fragments P0-P8 at an equal molar ratio at 20 ℃ in the 10 mM phosphate 












Moreover, the second group of the fragments P5- P8 dissected in a very different way 
also gave rise to far-UV CD and HSQC spectra characteristic of disordered proteins 
(Figure 3.3.7), again indicating that the second group of fragments were also largely- 
disordered. In particular, HSQC spectra of the second set of fragments acquired in the 
absence and presence of 8 M urea were highly similar, even with many resonance 
peaks superimposable (Figure3.3.7). This remarkable observation strongly 
demonstrated that the disorder degree of these fragments in the native buffer was 
almost identical to that in the presence of 8 M urea. Furthermore, we also acquired CD 
and NMR spectra of the samples obtained by mixing protein fragments of the first 
group plus Nogo-A (1-200), the second group plus Nogo-A (1-200) or two groups 
together plus Nogo-A (1-200) at an equal molar ratio. No significant conformational 
changes were observed, thus suggesting that these mixtures were also highly 
disordered (Figure 3.3.8). In particular, hydrogen exchange experiments were also 
performed and the result showed that all HSQC peaks of the 15N-labeled fragments 
disappeared rapidly within the instrumental dead time when the lyophilized proteins 
were re-dissolved in D2O, thus confirming the significant flexibility of Nogo-A N-
terminus.         
          Based on these results, it appears that like Nogo-B N-terminus, the 1016-residue 
Nogo-A N-terminus are also predominantly disordered in the free state, thus belonging 
to so-called “intrinsically unstructured” protein family which are constituted of 








3.3.4. Discussion  
 
In addition to its originally-identified role in inhibiting neurite growth, more and 
more novel functions have been recently found to be associated with three Nogo 
proteins. For example, Nogo proteins are now not only recognized as signaling 
molecules mediating neurite growth, vascular remodeling and apoptosis, they were 
also demonstrated to be clustered on the cell surface, probably forming a channel or 
transporter (Dodd et al., 2005). Most dramatically, Nogo-A has been very recently 
defined as a morphogenic protein critical for generating and maintaining the tubular 
network of the endoplasmic reticulum (ER) (Gia  et al., 2006). 
In the present study, by use of a variety of computational and experimental 
methods, we have gained convincing results indicating that the 200-residue N- and 33-
residue C-termini of Nogo-B were all highly-disordered, without any populated 
secondary structure as well as tight tertiary packing. Even more interestingly, 
bioinformatics, CD and NMR results with 8 systematically-dissected fragments of the 
Nogo-A N-terminus strongly implied that like Nogo-B, the 1016-residue Nogo-A N-
terminus might also be highly-unstructured. Our present results therefore ranked the 
N- and C-termini of Nogo molecules as new members of “intrinsically unstructured” 
protein family. Overall, it has been estimated that only about 2% archaeal but up to 
33% eukaryotic proteins contain long disordered regions. Another study revealed that 
in the eukaryote more than 20% of protein residues fall into locally disordered regions 
and 50-60% of known proteins have at least one long disordered segment (Tompa et 





proteins were proposed to be highly advantageous for special categories of functions 
including signal transduction, regulation, cytoskeletonal organization, protein-DNA 
recognition and human cancer. For example, unstructured regions offer unique 
capacity to harbor many important recognition motifs for binding to multiple partners. 
Indeed, our ELM analysis revealed that Nogo-A and Nogo-B, especially their N-
termini carry many linear binding motifs for SH3, SH2, WW and PDZ domains. 
Experimentally, Nogo-B was demonstrated to associate with Nck2 adaptor protein via 
its N-terminus. Notably, it has been recently proposed that being intrinsically-
unstructured will give rise to a novel mechanism to achieve functional moonlighting 
which means the same region of a protein may implement multi-functions (Tompa et 
al., 2005).  On the other hand, alternative splicing was suggested to be directly 
associated with radical appearance of intrinsically-unstructured proteins in 
multicellular organisms. In other words, the moonlighting nature of intrinsically-
unstructured proteins may offer accommodation for the functional complexity 
demanded by the evolution of multicellular organisms (Romero et al., 2005). 
One relatively-less explored functional category proposed for intrinsically 
unstructured proteins is their roles in underlying endocytosis as well as generating/ 
maintaining membrane structure. With regard to this, Nogo molecules may serve as a 
nice model for further investigations because they own unstructured N- and C-termini 
which have been extensively identified to be engaged in signaling transduction as well 
as regulating ER and cell membrane morphology. Therefore, it appears that being 
intrinsically-unstructured offers Nogo molecules the functional moonlighting, namely 





documented recently, one set of Nogo functions are engaged in cell-signaling essential 
for neuronal and cancer development via binding with various partners while another 
set are to serve as key components for forming cell surface machineries and 
controlling membrane morphology. Interestingly, integration of these two sets of 
functions in one molecule may represent a general mechanism by which membrane 
morphology and membrane-surface machinery are subjected to the direct regulation 
by cellular signaling networks. 
In summary, by an integrated use of various bioinformatics and experimental 
approaches, we have demonstrated that both N- and C-termini of Nogo molecules 
were intrinsically unstructured. Moreover, integration of two sets of above-mentioned 
functions in the Nogo molecule may represent a novel role for intrinsically-
unstructured proteins to place membrane-associated machineries under direct control 



















       3.4.    Identification of the Specific Molecular Interaction  















Previously, a various functions of Nogos have been identified. However, the 
molecular mechanism underlying these very diverse functions remains poorly 
understood. On the other hand, as mentioned in the last section, the N-terminus of 
NogoA/B revealed an extremely interesting fact that within this region, a total of 47 
proline residues exist and several proline-rich sequences appear to be potential SH3-
domain binding motifs. This observation strongly implies that at least some functions 
associated with this region would depend on interacting with the SH3 modular 
domains of a certain group of signaling proteins. In order to gain clues for constructing 
the molecule mechanism underlying Nogo functions, we selected the SH2/SH3-
containing adapter protein Nck2 which plays an integral role in converging 
transmembrane signals to the downstream signaling networks controlling 
cytoskeletonal dynamics (Tu et al., 1998; McCarty, 1998; Li et al., 2001; Buday et 
al.,2002). Very interestingly, the signaling networks mediated by Nogo and by 
ephrinB-Nck2 appear to have some overlapped functions although the underlying 
mechanism has not yet discovered (Sandvig et al., 2004 and Koeberle et al., 2004). In 
this study, the interaction between Nogo peptides and the human Nck2 were 
investigated by use of circular dichroism (CD), isothermal titration calorimetry (ITC) 
and NMR spectroscopy. 
 
3.4.1. NMR and ITC Characterization of the Binding between the hNck2 SH3 
domains and Nogo-A fragments 
 
NMR spectroscopy is a very powerful tool to detect weak or transit binding 
events, we therefore utilized NMR HSQC titration method to detect the possible 





A (1-200). We found that the first hNck2 SH3 domain was totally insoluble and 
consequently the study was focused on the second and third hNck2 SH3 domains. 
Table3.4.1 summarized the protein domains/fragments we used and the results 
obtained from the binding study. The initial HSQC screening indicated the binding 
interaction between the third hNck2 SH3 domain and Nogo-A (32-200). Subsequently 
we conducted a close examination of the amino acid sequence of Nogo-A (32-200) 
and three possible SH3 domain-binding motifs were spotted out. We thus chemically 
synthesized the three peptides, namely peptides Nogo-A (97-107), Nogo-A (141-150) 
and Nogo-A (171-181), and then undertook both NMR and ITC investigation on their 
interactions with the hNck2 SH3 domains. The results in Table3.4.1 indicated that 
only the thermodynamic parameters for the interactions with Nogo-A (32-200) and 
Nogo-A (171-181) peptides could be measured.  
Figure 3.4.1 presents the ITC profiles for the interactions of the third hNck2 
SH3 domain with Nogo-A (32-200) (Figure3.4.1a), and with Nogo-A (171-181) 
(Figure3.4.1b). After subtraction of the contribution of the corresponding blank 
titration, the two ITC profiles were fitted by the software ORIGIN to obtain two 
complete sets of thermodynamic parameters as shown in Table 3.4.2. The Kd for the 
binding between the third hNck2 SH3 domain and Nogo-A (171-181) reached 2.8 µM, 
indicating that this binding event ranks in the high-affinity SH3-ligand binding 
interactions in nature (Larson et al., 2000). In particular, this binding interaction is 
also very specific because no significant binding was detected between this peptide 







Table3.4.1. Binding interaction between the human Nogo-A fragments and hNck2 










Figure 3.4.1. ITC characterization of the binding interaction between the third 
hNck2 SH3 domain and Nogo-A fragments (a) Isothermal titration calorimetry (ITC) 
profile of the binding interaction between the third hNck2 SH3 domain and Nogo-A 
(32-200) at 298 K; (b) ITC profile of the binding interaction between the third hNck2 















































Table 3.4.2. Thermodynamic parameters of the binding interaction between 















between the third hNck2 SH3 domain and Nogo-A (97-107). Moreover, it is also very 
interesting to note that: 1) the binding of the third hNck2 SH3 domain with the 11-
residue peptide Nogo-A (171-181) is ~30 times more tight than that with Nogo-A (32-
200); 2) the binding with the short peptide Nogo-A (171-181) released heat while the 
binding with the larger fragment Nogo-A (32-200) absorbed heat. The observations 
may result from several possibilities: 1) in the much larger Nogo-A (32-300) molecule, 
the SH3 binding site may be buried by the residual structures which may need the 
binding with other proteins to have them disrupted to expose the SH3-binding site; 2) 
the presence of the large flexible regions other than the binding site may significantly 
reduce the binding affinity; or 3) both effects combined together. 
 
3.4.2. Identification of the Binding residues involved in the interaction between 
the third hNck2 SH3 Domain and Nogo-A Peptide 
 
        The successful identification of the tight binding between the third hNck2 SH3 
domain and Nogo-A (171-181) thus urges the availability of the high-resolution 
binding interfaces. Other graduate student (Liu Jinxian) in our lab determined the 
solution structure of the third hNck2 SH3 domain (Figure3.4.2) and further he maped 
the high-resolution binding interface of the third SH3 domain with the Nogo-A (171-
181) from the HSQC titrations at a molar ratio of 1:2 (SH3/peptide). The significantly 
affected residues were located over three regions, namely, the RT loop, the n-Src loop, 
and the 310-helix, consistent with the previously accepted notion that both the affinity 
and the specificity of the SH3-ligand interaction are mainly mediated by an interfacial 
region constituted by residues scattered over these three regions.  












Figure 3.4.2. NMR structures of the third hNck2 SH3 domain (a) Backbone 
superimposition of the 10 lowest-energy NMR structures of the third hNck2 SH3 
domain determined in the 25 mM phosphate buffer (pH 6.8) at 293 K. (b) Sausage 
representation of the backbones of the above 10 structures. The radius of the cylinder 
is proportional to the backbone RMS deviation calculated on the 10 lowest energy 
structures. The five well-conserved β-sheet segments and three binding important 
regions (RT loop, n-Src loop and 310-helix) typical of SH3 domains are labeled. (c) 











identified in this study, we labeled the Nogo-A peptide with 15N and subsequently 
monitored its HSQC peak shifts induced by adding an excess of the unlabeled SH3-3 
domain. The results indicated that upon binding the majority of the HSQC peaks  
shifted. In particular, HSQC peaks of Ala5 and Arg8 were significantly shifted. As 
judged from its sequence, Nogo-A peptide belongs to the class II SH3 ligands which 
have a consensus sequence of xPx#Px. While x can be any amino acid, # is a 
hydrophobic residue (usually Leu, Pro, or Val). To this end, the significant shift of the 
Arg8 peak was anticipated because this residue was thought to play a critical role in 
binding with SH3 domains. By contrast, Ala5 with a dramatic peak shift was not 
commonly found at that position of the class II ligands. Interestingly, Prk2, another 
high-affinity ligand for the hNck2 SH3-3 domain, also has an Ala at that position. This 
observation implied that the Ala residue at this position might play an important role 
in specifying the ligand preference for the hNck2 SH3-3 domain.  
 
3.4.3. Discussion 
So far, the most characterized binding partner for Nogo molecules is the Nogo-
66 receptor named NgR. It has been extensively thought that NgR receives neurite 
inhibitory signal placed by the Nogo-66 and further transducts it down via co-receptor    
p75(NTR) or/and a TNF receptor TROY. However, other functional receptors are 
poorly-understood. Therefore, further efforts are certainly demanded to identify more 
possible Nogo binding partners. In the current study, for the first time we identified the 
third hNck2 SH3 domain to be able to bind to a proline-rich motifs located within the 









           
                                                      
                  
Figure 3.4.3. the interaction between the third hNck2 SH3 domain and the 




















finding thus offers a critical clue to facilitate further in vivo exploring of the molecular 
mechanism underlying Nogo functions. Indeed, accumulating evidences support the 
pivotal role of the Nck proteins in coordinating many cellular signaling networks 
which control axonal guidance, neuronal development, plasticity and regeneration, as 
well as tumorigenesis (Tu et al., 1998; McCarty, 1998; Li W et al., 2001; Buday et al., 
2002). One key network relayed by Nck2 is Eph-ephrinB signaling which seems to 
have an overlapped functional spectrum with Nogo molecules (Flanagan et al., 1998; 
Song, 2003). If there does exist the communication/interplay between ephrin and 
Nogo signaling networks, one convergence point could be the Nck2 adapter protein. 
      To date, several hundreds of SH3 modular domains have been identified since its 
first discovery (Cicchetti et al., 1992; Mayer, et al., 1988; Mayer, 2001). This large 
family of the modular domains has been found to play a central role in connecting, 
integrating and regulating cell signaling via binding to proline-rich peptide motifs. In 
general, SH3 domains recognize and bind to their peptide ligands with a relatively low 
affinity and specificity and it was proposed that this feature offers SH3 domains a 
great advantage to coordinate and regulate the information flow occurring in cells 
(Mayer, 2001). However, the fundamental principle underlying the SH3 binding 
affinity and specificity remains largely unclear despite extensive studies. Here, with 
assistance of NMR spectroscopy and ITC, we succeeded first in identifying the 
interaction between the third hNck2 SH3 domain with the Nogo-A peptide and 
subsequently in correlating the structural details to thermodynamic parameters. It is 
worth to note that the Nogo-A (171-181) peptide owns a tight and specific binding to 





holds potential to be directly used to interfere in the cell signaling to explore its 
functional relevance. Moreover, it also provides a promising starting point for future 

























3.5. Rescuing Abandoned Proteins with Water: CD and    
               NMR Studies of Protein Fragments Solubilized in 















Very unexpectedly, during the process of studying the structure of NogoA/B, 
we surprisingly discovered that several buffer-insoluble Nogo-66 fragments could be 
easily solubilized in the water at high concentrations. In particular, this discovery 
allowed us to determine the NMR structure and dynamics of Nogo-60 and 
subsequently obtained a critical rationale to further design the structured and buffer-
soluble Nogo-54 (Li et al., 2006). This result inspired a question whether other buffer-
insoluble proteins also could be solubilized in water. Surprisingly, all 11 buffer-
insoluble protein fragments/domains in our lab, which are very diverse in cellular 
function, location, and molecular size, could be dissolved in salt-free water at high 
concentrations. 
 
3.5.1. Nogo-66 fragments 
  
Previously Nogo-66 was found totally insoluble in buffer and as such only 
Nog-40 with C-terminal 26 residues removed was studied with the presence of 50 % 
TFE (Li M et al., 2004). However, we recently discovered that Nogo-66 could be 
easily solubilized in the salt-free water at a high concentration. Whereas Nogo-66 had 
a far-UV CD spectrum typical of helical structure (Figure 3.5.1a), only five HSQC 
peaks resulting from non-His-tag residues were detectable (Figure3.5.1b). This 
observation was attributed to conformational exchanges on the microsecond to 
millisecond timescale. On the other hand, although two truncated forms, namely 
Nogo-60 and Nogo-(21-60) were again only soluble in salt-free water, they both have 
helical CD spectra (Figure 3.5.1, c and e) and well-separated HSQC spectra, with 







Figure 3.5.1. CD and HSQC characterization of Nogo-66 fragments   
Far-UV CD and NMR HSQC spectra of Nogo-66: a)-b); Nogo-60: c)-d); and Nogo-
(21-60): e)-f). All three peptides were only soluble in the salt-free water (pH 4.0), with 
protein concentrations of ~100 μM for Nogo-66; ~200 μM for Nogo-60 and Nogo-
(21-60). NMR spectra were acquired on a Bruker Avance 800 MHz NMR 
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Figure 3.5.2. Conformational properties of Nogo-54 (a) Structure of Nogo-54.  b)-c) 
Far-UV CD and NMR HSQC spectra of Nogo-54 in the salt-free water (blue) and in 
10 mM phosphate buffer (red) at pH 4.2 and 20 ºC. The protein concentrations of the 
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led to our previous determination of the solution structure and dynamics of Nogo-60, 
as well as further design of Nogo-54, which was structured and soluble in both salt-
free water and buffer. It is worthwhile to point out that the structures of Nogo-54 in 
salt-free water and buffer were essentially the same, as is clearly evident from its 3D 
structure and its superimposable CD and HSQC spectra (Figure 3.5.2).  
 
3.5.2. Extracellular Receptor (NgR)   
In the native proteins, disulfide bridges were needed for NgR: five disulfides 
were expected for N-terminal NgR and six for the entire NgR. In our previous 
investigation, these two proteins lacking disulfide bridge(s) were totally insoluble. 
Nevertheless, to our great surprise, in the present study they were all soluble in the 
salt-free water.  
          The 319-residue N-terminal NgR contained a leucine-rich repeat fold plus two 
C-terminal helical regions. As shown in Figure 3.5.3c, the disulfide-free N-NgR had a 
CD spectrum for a helical protein. As seen in the N-NgR structure (He et al., 2003) 
(Figure 3.5.3g), although the leucine-rich repeat fold contained many short β-strands 
additional to helical segments, they usually gave rise to helical-like CD spectra 
probably due to the unique solenoid-like fold they adopt (Fralish et al., 2003; Stumpp 
et al., 2003). Therefore if judged from its CD spectrum (Figure 3.5.3c), it might be 
concluded that the native-like secondary structure might already form in the disulfide-
free N-NgR. On the other hand, N-NgR owned a HSQC spectrum with a narrow 
dispersion (~0.7 ppm over proton and ~17 ppm over 15N dimensions) and very broad 





disulfide-free N-NgR underwent intermediate conformational exchanges or/and 
dynamic aggregation largely owing to its dynamic side-chain packing. Addition of 8M 
urea resulted in no significant change in the near-UV spectra (spectra not shown), 
again indicating that the side-chain packing was largely disrupted. However, 
introduction of 8 M urea again led to appearance of much more HSQC peaks, (Figure 
3.5.3b). Moreover, the entire 421-residue NgR with an 103-residue C-terminal 
extension also behaved similarly as N-NgR (Figures 3.5.3c ,d) although the structure 
of the extended 103-residues remained completely unknown. These results together 
suggested that although the disulfide-free N- and entire NgR proteins could be 
dissolved in the salt-free water, they were trapped in the molten globule states with 
both a native-like secondary structure and tertiary topology, but without a tight side-
chain packing largely due to the complete absence of essential disulfide bridges. In 
this regard, it appeared that although the disulfide formation is not essential for folding, 
it is vital for maintaining protein stability and tight side-chain packing (Song et al., 
1997; Luo et al., 1999; Redfield et al., 1999). 
 
3.5.3. Other proteins  
        Besides Nogo-66 fragments and NgR fragments, actually all of the buffer-
insoluble proteins in our lab were demonstrated to be easily dissolved by salt-free 
water. They includes disulfide-free extracelluar receptor domain form human Claudin1; 
intracellular protein Wrch1 CDC42-like domain and hNck2 SH3-1 with a Val insertion; 
two G-protein fragments of Nipah virus (Niv-44 and Niv-88) and viral hemagglutinin 











Figure3.5.3. CD and HSQC characterization of extracellular domains of 
transmembrane receptors  a)-b): Far-UV CD and HSQC NMR spectra of the N-
terminal domain (318 residues) of the human Nogo-66 receptor (NgR) in the absence 
of (blue) and in the presence of (red) of 8 M urea at pH 4.2 and 20 ºC.  c)-d): Far-UV 
CD and HSQC NMR spectra of the entire extracelluar domain (420 residues) of the 
same NgR respectively in the absence of (blue) and in the presence of (red) of 8 M 
urea at pH 6.2 and 20 ºC. The protein concentrations of the NMR samples were ~120 
μM for both N-NgR and NgR.  (e) Crystallographic structure of the NgR N-terminal 
domain (1OZN) which adopts a typical leucine-rich repeat fold. The protein samples 





























fragments/domains can be categorized into three groups. The first group has no 
secondary structure, as judged by CD, and has narrowly-dispersed HSQC spectra with 
sharp peaks. This group includes 152-residue viral hemagglutinin RBD and 58-residue 
hNck2 first SH3 domain. The second group possesses secondary structure based on 
CD assessment, but broadened HSQC peaks. Consequently, only a small set of HSQC 
peaks was detectable. Similar to Nogo-66 and NgR fragments, 86-residue Niv-86 and 
174-residue Wrch1 Cdc42-like domain belongs to this group.  The third group has 
secondary structure based on CD assessment, but, again, narrowly-dispersed HSQC 
spectra. However, these have well-separated HSQC peaks and thus were suitable for 
further high-resolution NMR study. In addition to Nogo-60 (60 residues) and Nogo-
(21-60) (40-residues), Niv-44 (44 residues) and Claudin-51 (51 residues) are classed 
into this group.  
 
3.5.4. Discussion  
Proteins are important functional players which implement the most difficult but 
essential tasks in living cells (Pace et al., 2004). However, one commonly-encountered 
problem in protein research and application is their insolubility (Chi et al., 2003). For 
example, in most structure genomics initiatives it has been estimated that ~35 %-50 % 
of the proteins expressed in Escherichia coli cells were in inclusion bodies, most of 
which were not refoldable in buffer systems (Christendat, et al., 2000; Pedelacq et al., 
2002) with available methods. In fact, it is extensively found that many proteins 
misfold and subsequently aggregate when overproduced in microorganisms (Pedelacq 
et al., 2002), although it remains unknown whether these proteins will misfold in vivo. 





cells by fusing with a highly-soluble tag; coexpressing folding catalysts and 
chaperones; reducing culture temperature; and modifying culture media, these 
approaches do not always work (Tsumoto et al., 2004). This observation implies that 
the intrinsic property of proteins may be a crucial determinant for protein insolubility. 
Therefore, structural characterization of insoluble proteins will provide valuable 
insights and consequently offer rationales for enhancing protein solubility. 
Unfortunately, to date no general method is available to solubilize these proteins 
without addition of detergents or/and denaturants such as SDS, urea and guanidine 
hydrochloride at high concentrations. It is really a great surprise to find that buffer-
insoluble proteins in our experiments could be solubilized in the salt-free water and 
most them are partially structured to some extend. Very strikingly, we failed to find 
any protein fragment/domain with a tight tertiary packing. This observation strongly 
implies that proteins are insoluble in buffers, probably because they lack an intrinsic 
propensity to reach or/and maintain the well-packed native state and consequently 
were trapped in the molten-globule or highly-disordered states, which have a 
tremendous tendency to aggregation in the presence of salt ions. However, such 
buffer-insoluble proteins may just account for a portion of denatured and partially-
folded proteins, because it is well known that many denatured, partially-folded, as well 
as "intrinsically-unfolded", proteins are soluble in buffer systems. In fact, the 
solubility of many intrinsically-unfolded proteins was found to be high because they 
usually have relatively low hydrophobicity. 
         Water bears a variety of unique properties, many of which remain poorly-





water and consequently the existence of water on other planets in the universe is a sign 
that the extra-terrestrial life might origin and evolve there (Transcript of final 
discussion session for Meeting Issue, 2004). On Earth, almost every activity in living 
cells is occurring in water-based media but mostly with the presence of salt ions. 
Usually to enhance protein solubility, the common method is to add more agents such 
as detergents, denaturants or arginine (Ishibashi et al., 2005) into the solution, 
however unexpectedly; buffer-insoluble proteins could be easily dissolved by salt-free 
water. Actually, almost all of buffer-insoluble proteins in our lab could be dissolved in 
the salt-free water at high concentrations. Based on our present study; it seems that 
“double purity” is needed to get buffer-insoluble proteins dissolved in the salt-free 
water. In other words, not only the purity of water matters, the purity of the protein is 
also essential. It appears that proteins have to be highly-purified from other molecules 
such as lipid by affinity chromatography followed by reverse-phase HPLC purification. 
Probably the existence of these molecules even in a tiny amount may block proteins 
from optimistically-interacting with water, probably by sticking to the exposed 
hydrophobic patches of proteins. For example, it seemed impossible to directly 
dissolve buffer-insoluble proteins out of lyophilized inclusion bodies with the salt-free 
water.  
It would be reasonable to contemplate that if not all, at least the majority of 
previously-deserted proteins can be solubilized in the salt-free water for further study, 
as exemplified on Nogo-60. On the other hand, it appears extremely challenging to 
fully understand the molecular mechanism underlying the solubilization of buffer-





protein aggregation is dominated by the intermolecular hydrophobic clustering and 
salt has significant effects on this process (Burgering et al. 1994; Baldwin, 1996; 
Neagu et al., 2001; Ramos et al., 2002; Chi et al., 2003; Zhou, 2005). The salt ion is 
thought to have both “salting-in” and “salting-out” effects on protein solubility. In 
other words, salts at a low concentration enhance protein solubility while salts at a 
high concentration reduce solubility. Interestingly, it was recently reported that under 
some conditions, in particular when the protein molecules bear a significant amount of 
net charges, only “salting-out” effects could be observed and consequently proteins 
should have the highest solubility in aqueous solution with the near-zero ionic strength 
(Retailleau, et al., 1997; Ruckenstein et al., 2006).Theoretically, it was proposed that 
the net interaction between two charged particles such as protein molecules is the 
balance between the repulsive electrostatic contribution and the attractive van der 
Waals contribution. Therefore, the repulsive electrostatic interactions between two 
charged protein molecules will be reduced by increasing ionic strength (Retailleau et 
al., 1997). To explain our results, here we propose that buffer-insoluble-proteins lack 
intrinsic ability to reach or/and maintain a well-packed native conformation in which 
most hydrophobic side-chains are well-buried in the structural core. Instead, they are 
trapped in the partially-folded states in which the majority of hydrophobic side-chains 
are exposed to the bulk-solvent. As such, a very low ionic strength is sufficient to 
screen out intrinsic repulsive interactions such as electrostatic interaction and 
consequently the hydrophobic clustering/aggregation will be occurring. However, our 
current results seem revealing a marvelous fact that when proteins are originally 





potential to manifest their full spectrum of structural states by utilizing intrinsic 
repulsive interactions to suppress the attractive hydrophobic clustering in the pure 
water.  
In conclusion, our study seems revealing that if not all, at least the majority of 
buffer-insoluble proteins can be dissolved in the pure water to manifest their intrinsic 
conformational states without going to significant aggregation. This finding bears 
significant implications not only in practical applications, but also in our 
























































































          Due to the highly-diverse spectrum of biological functions of Nogo, it has been 
extensively proposed that in addition to NgR, Nogo proteins should have many other 
unidentified receptors and binding partners. Indeed, we have previously demonstrated 
that Nogo-A and Nogo-B might be associated with the third SH3 domain of Nck2 
adaptor protein via a short proline-rich motif over its N-terminus. Strikingly, a novel 
transmembrane protein has been recently identified to be a specific receptor for the 
amino terminus of Nogo-B (AmNogo-B) and thus termed NgBR (Miao et al., 2006). 
The 297-residue NgBR is a hypothetical protein with its ectodomain showing no 
homology with any known protein but with its cytoplasmic domain bearing a high 
similarity to the cis-prenyltransferase family of lipid-modifying enzymes. However, 
despite this sequence similarity, no lipid transferase activity was detected for the 
NgBR cytoplasmic domain (Miao et al., 2006). The NgBR protein is involved in 
stimulating chemotaxis and morphogenesis of endothelial cells and was found to be 
highly expressed in mouse heart, liver, kidney, and pancreas. NgBR is not only 
colocatized with Nogo-B during angiogenesis in vivo, but also specifically interacted 
with AmNogo-B and consequently mediates chemotaxis and 3D tube formation of 
endothelial cells in vitro (Miao et al., 2006).  
       Structural characterization of NgBR represents an essential step to gain an insight 
into the molecular mechanism underlying the interaction between AmNogo-B and 
NgBR as well as to gain rationales for further development of agents of therapeutic 
interest. Therefore in the present study we initiated cloning and expression as well as 
further CD and NMR characterization of NgBR and its two dissected domains. Very 





unstructured while its cytoplasmic domain is only partially-folded. Our present 
findings may provide important clues for further understanding of functional roles of 
NgBR. 
 
3.6.1. Cloning and expression of NgBR and its dissected domains 
        The full-length NgBR, as well as its cytoplamic domain and ectodomain were 
successfully cloned into pGEX 4T-1 or pET32a vector with BamHI/XhoI restriction 
sites and expressed as GST-fused or His-tagged proteins. The NgBR ectodomain was 
expressed as a GST fusion protein which was purified under native condition (Figure 
3.6.1b). After removing the GST by in-gel thrombin cleavage, the NgBR ectodomain 
was further purified by HPLC. On the other hand, the His-tagged cytoplasmic domain 
and full-length NgBR were found to exist in the inclusion body. As such the two 
recombinant proteins were first purified by Ni2+-affinity column under denaturing 
condition (Figure3.6.1c, d) followed by HPLC purification. The molecular weights of 
all three recombinant proteins determined by MALDI-TOF mass spectrometry 
matched those predicted from their amino acid sequences. 
        The lyophilized proteins of the full-length NgBR and its cytoplasmic domain 
were found to be highly insoluble in salty buffer, but strikingly could be solubilized in 
salt-free water (pH 4.5) to high concentrations, as we previously discovered. However, 
we failed to adjust their solution pH to a high value because addition of a tiny amount 
of NaOH would result in a rapid aggregation. On the other hand, the solubility of the 
NgBR ectodomain was very high in salty buffer and thus all studies on it were 








Figure3.6.1. Domain organization of NgBR and its expression and purification 
(a). Bioinformatics characterization reveals that NgBR contains a putative signal 
sequence (1-46), an ectodomain (47-120), a type 1A transmembrane domain (121-139) 
and a cytoplasmic domain (140-297). (b). Coomasie brilliant blue stained SDS-PAGE 
gel showing the expression and affinity-purification of the NgBR ectodomain. Line 1: 
total cell extract after IPTG induction; Line 2: Supernatant of the cell lysate; Line 3: 
GST beads with bound GST-fused ectodomain; Line 4: GST beads after in-gel 
thrombin cleavage; Line 5: protein molecular weight markers. (c). Coomasie brilliant 
blue stained SDS-PAGE gel showing the expression and affinity-purification of the 
NgBR cytoplamic domain. Line 1: total cell extract before IPTG induction; Line 2: 
total cell extract after IPTG induction; Line 3: Supernatant of the cell lysate; Line 4: 
pellet of the cell lysate; Line 5: Ni-agrose beads with bound cytoplamic domain in 
presence of 8 M urea; Line 6: protein molecular weight markers. (d). Coomasie 
brilliant blue stained SDS-PAGE gel showing the expression and affinitypurification 
of the full-length of NgBR. Line 1: total cell extract before IPTG induction; Line 2: 
total cell extract after IPTG induction; Line 3: Supernatant of the cell lysate; Line 4: 
pellet of the cell lysate; Line 5: Ni-agrose beads with bound NgBR in presence of 8 M 







3.6.2. Bioinformatics characterization 
 
         As seen in Figure 3.6.2a and 3.6.2b, analysis of NgBR by IUPred and VSL2B 
indicated that the N-terminal 50 residues out of the 74-residue NgBR ectodomain had 
a very high tendency to be disordered while the cytoplasmic domain was much more 
structured despite also owning a relatively-disordered fragment (Figure 3.6.2b). 
Consistent with this, secondary structure prediction by PREDATOR indicated that the 
majority of the ectodomain was random coil while the large portion of the cytoplasmic 
domain formed helix and beta-sheet secondary structures (results not shown). 
Interestingly, examination of the amino acid sequence revealed an interesting fact that 
up to 10 proline residues existed in the 74-residue ectodomain (Figure 3.6.2c). High 
proline content has been previously proposed to be associated with the lack of a 
defined tertiary structure (Romero P et al., 2001 and Tompa P et al., 2000) 
 
3.6.3. Structural characterization of the NgBR ectodomain 
      Figure 3.6.3a present the far-UV CD spectrum of the NgBR ectodomain which 
owned the largest negative signal at ~198 nm and had no positive signal at ~190 nm, 
indicating that it was predominantly unstructured. Furthermore, no significant 
difference was detected for its near-UV CD spectra in absence and presence of 8 M 
urea (Figure 3b), suggesting that the no tight tertiary packing existed in the NgBR 
ectodomain. More specifically, the 1H-15N NMR HSQC spectrum of the NgBR 
ectodomain displayed very narrow spectral dispersions over both dimensions (~0.75 






Figure 3.6.2 Bioinformatics analysis of NgBR. (a). The globularity and disordered 
regions of NgBR assessed by IUPRED; and (b). by VSL2B. (c) Amino acid sequence 




































































Figure 3.6.3. CD and NMR characterization of the NgBR ectodomain (a). Far-UV 
CD spectrum in 20 mM phosphate buffer (pH 6.0) at 25°C.(b). Near-UV CD spectra 
in the absence (blue) and presence (pink) of 8 M urea in 20 mM phosphate buffer (pH 
6.0) at 25°C. (c). 1H-15N NMR HSQC spectrum at a concentration of 350 μM acquired 












for almost all residues (Figure 3.6.3b). These characteristics indicated that the NgBR 
ectodomain is highly disordered in the free state. It was also noticeable that there were 
some extra weak peaks in the HSQC spectrum (Figure 3.6.3c), similar to our previous 
observation on the Nogo-B Nterminus which was also abundant in proline residues. 
Therefore, these weak peaks were also likely to result from the cis-trans isomerization 
of the proline residues in the NgBR ectodomain. Similar to the situation we 
encountered with Nogo-B, the extensive presence of the cis-trans isomerization made 
it impossible to achieve NMR sequential assignment of the unstructured and proline-
rich NgBR ectodomain. 
 
3.6.4. Structural characterization of NgBR and its cytoplasmic domain 
       Despite very poor solubility of NgBR and its cytoplasmic domain in salty buffer, 
they could be easily solubilized in salt-free water to a high concentration of ~450 μM. 
This thus allowed us to structurally characterize the two recombinant proteins. As 
shown in Figure 3.6.4a, the far-UV CD spectra of NgBR and its cytoplamic domain 
are very similar, with one positive signal at ~190 nm and two negative signals at ~205 
and 222 nm respectively, indicating that both proteins contained high contents of 
helical structures. Indeed, analysis of the two CD spectra by K2d (Andrade et al., 1993) 
indicated that NgBR contained 38 % α-helix, 15 % β-sheet and 47 % random coil 
while the cytoplasmic domain had 45 % α-helix, 23 % β-sheet and 32 % random coil. 
On the other hand, very small differences of the near-UV spectra of NgBR (Figure 





urea implied that both of them had no tight tertiary packing and as such they were only 
partially-folded. 
        Indeed, 1H-15N NMR HSQC spectra of NgBR (Figure 3.6.4d) and its cytoplasmic 
domain (Figure 3.6.4e) again showed very narrow spectral dispersions over both 
dimensions (~0.8 ppm for 1H and ~20 ppm for 15N), clearly confirming the conclusion 
that they were only partially-folded based on the above CD results. Furthermore, 
unlike the NgBR ectodomain, in the absence of 8 M urea, only ~45 resonance peaks 
could be detected for the 250-residue NgBR (Figure 3.6.4d) and ~30 peaks (Figure 
3.6.4e) for the 157-residue cytoplasmic domain. On the other hand, introduction of 8 
M urea resulted in a sudden appearance of a large amount of HSQC resonance peaks 
for both NgBR and its cytoplasmic domain. This observation revealed that unlike the 
NgBR ectodomain which was highly-disordered in solution, the cytoplasmic domain 
was partially-folded but a large portion of the molecule was undergoing 
conformational exchanges on the μs-ms time-scale or/and dynamic aggregation due to 
the lack of a tight tertiary packing. Consequently, most NMR HSQC resonance peaks 
were severely broadened and thus became undetectable, which made it impossible to 
carry out further high-resolution NMR investigation (Song et al., 1999 and Wei  et al., 
2005) In this regard, the NgBR cytoplasmic domain belongs to the second group of the 







Figure 3.6.4. CD and NMR characterization of the full-length NgBR and its 
cytoplamic domain (a). Far-UV CD spectra of the full-length NgBR (pink) and its 
cytoplamic domain (blue) in salt-free water (pH 4.5) at 25 ºC. (b). Near-UV CD 
spectra of the full-length NgBR in the absence (blue) and presence (pink) of 8 M urea 
in salt-free water (pH 4.5) at 25°C. (c). Near-UV CD spectra of the NgBR cytoplamic 
domain in the absence (blue) and presence (pink) of 8 M urea in salt-free water (pH 
4.5) at 25 °C. (d). 1H-15N NMR HSQC spectra of the 15N-labeled cytoplamic domain 
in the absence (red) and presence (black) of 8 M urea at a protein concentration of 450 
μM acquired in salt-free water (pH 4.5) at 25 ºC. (e). 1H-15N NMR HSQC spectra of 
the 15N-labeled full-length NgBR in the absence (red) and presence (black) of 8 M 









        The discovery of the Nogo-B specific receptor NgBR significantly advanced our 
understanding of the molecular mechanism underlying the diverse functions of Nogo 
proteins. In particular, the key role of the AmNogoB-NgBR interaction in mediating 
chemotaxis and 3D tube formation ranks NgBR as an extremely promising target for 
design of agonists or antagonists of this pathway to modulate vascular remodeling and 
angiogenesis (Miao et al., 2006). Previously we have conducted a systematical  
characterization of the structural and binding properties of Nogo proteins. In the 
present study, we initially attempted to determine the structure of NgBR. To our big 
surprise, the bioinformatics, CD and NMR characterization reveals that the NgBR 
ectodomain is a member of the intrinsically unstructured protein (IUP) family. 
Previously, the very unusual properties of the intrinsically-unstructured family of 
proteins have been proposed to be advantageous for special categories of biological 
functions including signal transduction, regulation, cytoskeletonal organization, 
protein-DNA recognition, human cancer, endocytosis as well as 
generating/maintaining membrane structure. However, the commitment of an 
intrinsically-unstructured protein as the ectodomain of a transmembrane receptor was 
rarely reported. Previously, the ectodomain of the transmembrane beta-dystroglycan 
was characterized to be an intrinsically-unstructured protein (Bozzi et al., 2003). 
However, the known function of the betadystroglycan ectodomain is to constitute a 
dystroglycan complex by binding alphadystroglycan which is separated from beta-
dystroglycan by a posttranslational cleavage of a single proprotein at Ser654. To this 





(Winder, 2001). Our current finding raises an intriguing question as how the 
intrinsically-unstructured NgBR ectodomain functions. It appears that there are three 
possible mechanisms. The first one is that the NgBR ectodomain becomes well-
structured upon binding to Nogo-B or other partners. Alternatively it is also possible 
that unlike the classic receptor ectodomains, the NgBR ectodomain may function more 
like a scaffold to utilize short motifs to assemble a variety of binding partners over the 
cell surface. The third one is that similar to beta-dystroglycan, the NgBR ectodomain 
is a component of a multi-component receptor complex. However, if only considering 
its interaction with Nogo-B, it is very unlikely that upon binding they will form a well 
structured complex as both NgBR ectodomain and Nogo-B N-terminus are highly 
unstructured as well as proline-rich. Certainly, intense studies are demanded to address 
this unusual property of NgBR in the future. 
          It is also valuable to discover that the full-length NgBR and its cytoplamic 
domain are highly insoluble in salty buffer but again could be easily solubilized in 
salt-free water to reach a concentration of 450 μM. Although previously we have 
demonstrated that salt-free water was able to solubilize all buffer-insoluble proteins 
we had at that time, the present result not only provides support but also extends our 
previous discovery by showing that salt-free water is even capable of dissolving the 
fulllength NgBR carrying a transmembrane fragment. Moreover, the observation that 
the NgBR cytoplasmic domain is only partially-folded supports the previous 
speculation that it may serve as a scaffold responsible for binding isoprenyl lipids 
and/or prenylated proteins , rather than as a lipid transferase enzyme because in 





It is highly possible that the NgBR cytoplasmic domain becomes well-folded upon 




































































































Recently RTN4/Nogo proteins have received intense attentions because 
they have been implicated in a variety of critical cellular processes including CNS 
neuronal regeneration, vascular remodeling, apoptosis, interaction with β-amyloid 
protein converting enzyme (BACE) and formation/maintenance of the tubular network 
of the endoplamic reticulum (ER). Knowledge of the three-dimensional structures of 
Nogo proteins is crucial for the better understanding of their functions as well as 
rational design of molecules of therapeutic applications by targeting protein-protein 
interaction interfaces between Nogo and the binding partners. By a combined use of 
molecular biology, biochemistry, biophysics and bioinformatics approaches, we 
provide the first complete picture of the Nogo structures and dynamics, which bears 
immediate implications in design of the therapeutic agencies.  
       The structural characteristics of the two identified inhibitory domains have been 
investigated by CD and NMR. 3D structure of Nogo-40 and Nogo-60 provides us 
important insight into the interaction between Nogo and NgR.  Moreover, based on the 
Nogo-60 NMR structure, we have successfully designed the structured and buffer-
soluble Nogo-54 with biological activity. Therefore, Nogo-54 can serve as a promising 
template for further design of more efficient Nogo-66 antagonists to promote the CNS 
neurite outgrowth. Except for Nogo-66 loop, both N- and C-termini of Nogo 
molecules were demonstrated to be intrinsically unstructured.  It appears that being 
intrinsically unstructured allows Nogo molecules to serve as double-faceted functional 
players, with one set of functions involved in cellular signaling processes essential for 
CNS neuronal regeneration, vascular remodeling, apoptosis and so forth ; and with 





specific interaction between Nogo peptides and SH3 domain of Nck2 offers a critical 
molecular clue for further in vivo investigation of the Nogo functions and its cross-
talks with other Nck2-coordinated signaling networks such as Eph-ephrinB signaling. 
In addition, the discovery of rescuing abandoned proteins with pure water not only 
gives a novel insight into the properties of insoluble proteins, but also bears significant 
implications in our understanding of fundamental regimes of proteins.  
          In the future, Nogo-54 will be a promising template for designing Nogo-66 
antagonist by varying the Nogo-54 sequence with site-directed mutagenesis. The 
whole design process would be tightly guided by ITC measurement and NMR 
methodology. The binding affinity and specificity of peptide antagonists can be further 
enhanced by modifying its side-chain or alternatively, by the computational docking 
method called virtual design. In vivo activity of the designed peptide antagonists 
would be firstly measured by neurite outgrowth assays, subsequently tested by animal 
model. On the other hand, we could go further to study the interaction between Nogo 
and other binding partners. Identification of the new binding partners and investigation 
on how these binding partners interact with Nogo functional domains will facilitate 
our understanding of the diverse biological functions, as well as further drug design.    
         In conclusion, the stuctures and dynamics of Nogo proteins, as well as their 
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Clustal W (1.83) RTNs sequence alignment 
reticulon1A      -----MAAPGDPQDELLPLAGPGSQWLRHRGEGENEAVTPKGATPAPQAGEPSPGLGARA 55 
reticulon1C      ------------------------------------------------------------ 
reticulon4A      -MEDLDQSPLVSSSDSPPRPQPAFKYQFVREPEDEEEEEEEEEEDEDEDLEELEVLERKP 59 
reticulon4B      -MEDLDQSPLVSSSDSPPRPQPAFKYQFVREPEDEEEEEEEEEEDEDEDLEELEVLERKP 59 
reticulon4C      ------------------------------------------------------------ 
reticulon3a      ------------------------------------------------MAEPSAATQSHS 12 
reticulon2A      MGQVLPVFAHCKEAPSTASSTPDSTEGGNDDSDFRELHTAREFSEEDEEETTSQDWGTPR 60 
reticulon2B      MGQVLPVFAHCKEAPSTASSTPDSTEGGNDDSDFRELHTAREFSEEDEEETTSQDWGTPR 60 
reticulon2C      ------------------------------------------------------------ 
                                                                              
 
reticulon1A      REAASREAGSGPARQSPVAMETASTGVAGVSSAMDHTFSTTSKDGEGSCYTSLISDICYP 115 
reticulon1C      ------------------------------------------------------------ 
reticulon4A      AAGLSAAPVPTAPAAGAPLMDFGNDFVPPAPRGPLPAAPPVAPERQPSWDPSPVSSTVPA 119 
reticulon4B      AAGLSAAPVPTAPAAGAPLMDFGNDFVPPAPRGPLPAAPPVAPERQPSWDPSPVSSTVPA 119 
reticulon4C      ------------------------------------------------------------ 
reticulon3a      ISSSSFGAEPSAPGGGG------------------------SPGACPALGTKSCSSSC-- 46 
reticulon2A      ELTFSYIAFDGVVGSGGRRDSTARRPRPQGRSVSEPRDQHPQPSLGDSLESIPSLSQSPE 120 
reticulon2B      ELTFSYIAFDGVVGSGGRRDSTARRPRPQGRSVSEPRDQHPQPSLGDSLESIPSLSQSPE 120 
reticulon2C      ------------------------------------------------------------ 
                                                                              
 
reticulon1A      PQEDSTYFTGILQKENGHVTISESPEELGTPGPSLPDVPGIESRGLFSSDSGIEMTPAES 175 
reticulon1C      ------------------------------------------------------------ 
reticulon4A      PSPLS-------AAAVSPSKLPEDDEPPARPPPPPPASVSPQAEPVWTPPAPAPAAPPST 172 
reticulon4B      PSPLS-------AAAVSPSKLPEDDEPPARPPPPPPASVSPQAEPVWTPPAPAPAAPPST 172 
reticulon4C      ------------------------------------------------------------ 
reticulon3a      ------------------------------------------------------------ 
reticulon2A      PGRRG-------DPDTAPPSERPLEDLRLRLDHLGWVARGTGSGEDSSTSSSTPLEDEEP 173 
reticulon2B      PGRRG-------DPDTAPPSERPLEDLRLRLDHLGWVARGTGSGEDSSTSSSTPLEDEEP 173 
reticulon2C      ------------------------------------------------------------ 
                        :  ::                                                 
 
reticulon1A      TEVNKILADPLDQMK--------------------------------------------- 190 
reticulon1C      ------------------------------------------------------------ 
reticulon4A      PAAPKRRGS------SGSVDETLFALPAASEPVIRSSAENMDLKEQPGNTISAGQEDFPS 226 
reticulon4B      PAAPKRRGS------SGSV----------------------------------------- 185 
reticulon4C      ------------------------------------------------------------ 
reticulon3a      ------------------------------------------------------------ 
reticulon2A      QEPNRLETG--------------------------------------------------- 182 
reticulon2B      QEPNRLETG--------------------------------------------------- 182 
reticulon2C      ------------------------------------------------------------ 
                           :  :                                               
 
reticulon1A      ---------------------------------------AEAYKYIDITRPEEVKHQEQH 211 
reticulon1C      ------------------------------------------------------------ 
reticulon4A      VLLETAASLPSLSPLSAASFKEHEYLGNLSTVLPTEGTLQENVSEASKEVSEKAKTLLID 286 
reticulon4B      ------------------------------------------------------------ 
reticulon4C      ------------------------------------------------------------ 
reticulon3a      ------------------------------------------------------------ 
reticulon2A      ------------------------------------------------------------ 
reticulon2B      ------------------------------------------------------------ 
reticulon2C      ------------------------------------------------------------ 
                                                                              
 





reticulon1C      ------------------------------------------------------------ 
reticulon4A      RDLTEFSELEYSEMGSSFSVSPKAESAVIVANPREEIIVKNKDEEEKLVSNNI--LHNQQ 344 
reticulon4B      ------------------------------------------------------------ 
reticulon4C      ------------------------------------------------------------ 
reticulon3a      ------------------------------------------------------------ 
reticulon2A      -EAGEELDLRLRLAQPSSPEVLTPQLSPGSGTPQAGTPSPSRSRDSNSGPEEPLLEEEEK 241 
reticulon2B      -EAGEELDLRLRLAQPSSPEVLTPQLSPGSGTPQAGTPSPSRSRDSNSGPEEPLLEEEEK 241 
reticulon2C      ------------------------------------------------------------ 
                         :                                                    
 
reticulon1A      RRAPQITTPVKITLTEIEPSVETTTQEKTPEKQDICLKPSPDTVPTVTVSEPEDDSPGSI 331 
reticulon1C      ------------------------------------------------------------ 
reticulon4A      ELPTALTKLVKEDEVVSSEKAKDSFNEKRVAVEAPMREEYADFKPFERVWEVKDSKEDSD 404 
reticulon4B      ------------------------------------------------------------ 
reticulon4C      ------------------------------------------------------------ 
reticulon3a      ------------------------------------------------------------ 
reticulon2A      QWGPLEREPVRGQCLDSTDQLEFTVEPRLLGTAMEWLKTSLLLAVYKTVPILELSPPLWT 301 
reticulon2B      QWGPLEREPVRGQCLDSTDQLEFTVEPRLL------------------------------ 271 
reticulon2C      ------------------------------------------------------------ 
                          :                                      :            
 
reticulon1A      TPPSSGTEPSAAESQGKGSISEDELITAIKEAKGLS------------------------ 367 
reticulon1C      ------------------------------------------------------------ 
reticulon4A      MLAAGGKIESNLESKVDKKCFADSLEQTNHEKDSESSNDDTSFPSTPEGIKDRSGAYITC 464 
reticulon4B      ------------------------------------------------------------ 
reticulon4C      ------------------------------------------------------------ 
reticulon3a      ------------------------------------------------------------ 
reticulon2A      AIGWVQRGPTPPTPVLRVLLKWAKSPRSSGVPSLSL------------------------ 337 
reticulon2B      ------------------------------------------------------------ 
reticulon2C      ------------------------------------------------------------ 
                                                                              
 
reticulon1A      ------------------------------------------------------------ 
reticulon1C      ------------------------------------------------------------ 
reticulon4A      APFNPAATESIATNIFPLLGDPTSENKTDEKKIEEKKAQIVTEKNTSTKTSNPFLVAAQD 524 
reticulon4B      ------------------------------------------------------------ 
reticulon4C      ------------------------------------------------------------ 
reticulon3a      ------------------------------------------------------------ 
reticulon2A      ------------------------------------------------------------ 
reticulon2B      ------------------------------------------------------------ 
reticulon2C      ------------------------------------------------------------ 
                                                                              
 
reticulon1A      ------------------------------------------------------------ 
reticulon1C      ------------------------------------------------------------ 
reticulon4A      SETDYVTTDNLTKVTEEVVANMPEGLTPDLVQEACESELNEVTGTKIAYETKMDLVQTSE 584 
reticulon4B      ------------------------------------------------------------ 
reticulon4C      ------------------------------------------------------------ 
reticulon3a      ------------------------------------------------------------ 
reticulon2A      ------------------------------------------------------------ 
reticulon2B      ------------------------------------------------------------ 
reticulon2C      ------------------------------------------------------------ 
                                                                              
 
reticulon1A      ----------------YETAENPRPVGQLADRPEVKARSGPPTIPSPLDHEASSAESGDS 411 
reticulon1C      ------------------------------------------------------------ 
reticulon4A      VMQESLYPAAQLCPSFEESEATPSPVLPDIVMEAPLNSAVPSAGASVIQPSSSPLEASSV 644 
reticulon4B      ------------------------------------------------------------ 
reticulon4C      ------------------------------------------------------------ 
reticulon3a      ------------------------------------------------------------ 
reticulon2A      ------------------------------------------------------------ 
reticulon2B      ------------------------------------------------------------ 
reticulon2C      ------------------------------------------------------------ 
                                          :                     :             
 
reticulon1A      EIELVSEDPMAAEDALPSGYVSFGHVGGPPPSPASPSIQYSILREEREAELD-------- 463 
reticulon1C      ------------------------------------------------------------ 
reticulon4A      NYESIKHEPENPPPYEEAMSVSLKKVSGIKEEIKEPENINAALQETEAPYISIACDLIKE 704 
reticulon4B      ------------------------------------------------------------ 
reticulon4C      ------------------------------------------------------------ 
reticulon3a      ------------------------------------------------------------ 
reticulon2A      ------------------------------------------------------------ 
reticulon2B      ------------------------------------------------------------ 
reticulon2C      ------------------------------------------------------------ 






reticulon1A      --------------SELIIESCDASSASEESPKREQDSPPMKPSALDAIREETGVRAEER 509 
reticulon1C      ------------------------MQATADSTK------------MDCVWSN-------- 16 
reticulon4A      TKLSAEPAPDFSDYSEMAKVEQPVPDHSELVEDSSPDSEPVDLFSDDSIPDVPQKQDETV 764 
reticulon4B      ------------------------------------------------------------ 
reticulon4C      ------------------------------------------------------------ 
reticulon3a      ------------------------------------------------------------ 
reticulon2A      ------------------------------------------------------------ 
reticulon2B      ------------------------------------------------------------ 
reticulon2C      ------------------------------------------------------------ 
                                 :                       :       :            
 
reticulon1A      APSRRGLAEPGSFLDYPSTEPQPGPELPPGDGALEPETPMLPRKPEEDS----------- 558 
reticulon1C      ------------------------------------------------------------ 
reticulon4A      MLVKESLTETSFESMIEYENKEKLSALPPEGGKPYLESFKLSLDNTKDTLLPDEVSTLSK 824 
reticulon4B      ------------------------------------------------------------ 
reticulon4C      ------------------------------------------------------------ 
reticulon3a      ------------------------------------------------------------ 
reticulon2A      ------------------------------------------------------------ 
reticulon2B      ------------------------------------------------------------ 
reticulon2C      ------------------------------------------------------------ 
                       :                   :             :                    
 
reticulon1A      ------------------------------------------------------------ 
reticulon1C      ------------------------------------------------------------ 
reticulon4A      KEKIPLQMEELSTAVYSNDDLFISKEAQIRETETFSDSSPIEIIDEFPTLISSKTDSFSK 884 
reticulon4B      ------------------------------------------------------------ 
reticulon4C      ------------------------------------------------------------ 
reticulon3a      ------------------------------------------------------------ 
reticulon2A      ------------------------------------------------------------ 
reticulon2B      ------------------------------------------------------------ 
reticulon2C      ------------------------------------------------------------ 
                                                                              
 
reticulon1A      ------------------------------------------------------------ 
reticulon1C      ------------------------------------------------------------ 
reticulon4A      LAREYTDLEVSHKSEIANAPDGAGSLPCTELPHDLSLKNIQPKVEEKISFSDDFSKNGSA 944 
reticulon4B      ------------------------------------------------------------ 
reticulon4C      ------------------------------------------------------------ 
reticulon3a      ------------------------------------------------------------ 
reticulon2A      ------------------------------------------------------------ 
reticulon2B      ------------------------------------------------------------ 
reticulon2C      ------------------------------------------------------------ 
                                                                              
 
reticulon1A      ------------------------------SSNQSPAATKGPGPLGPGAPPPLLFLNKQK 588 
reticulon1C      --------------------------------------------------------WKSQ 20 
reticulon4A      TSKVLLLPPDVSALATQAEIESIVKPKVLVKEAEKKLPSDTEKEDRSPSAIFSAELSKTS 1004 
reticulon4B      ------------------------------------------------------------ 
reticulon4C      -------------------------------------------------MDGQKKNWKDK 11 
reticulon3a      -----------------------------------------------------------A 47 
reticulon2A      -----------------------------------------------------GADMGSK 344 
reticulon2B      ------------------------------------------------------------ 
reticulon2C      --------------------------------------------------------MGSK 4 
                                                                              
 
reticulon1A      AIDLLYWRDIKQTGIVFGSFLLLLFSLTQFSVVSVVAYLALAALSATISFRIYKSVLQAV 648 
reticulon1C      AIDLLYWRDIKQTGIVFGSFLLLLFSLTQFSVVSVVAYLALAALSATISFRIYKSVLQAV 80 
reticulon4A      VVDLLYWRDIKKTGVVFGASLFLLLSLTVFSIVSVTAYIALALLSVTISFRIYKGVIQAI 1064 
reticulon4B      VVDLLYWRDIKKTGVVFGASLFLLLSLTVFSIVSVTAYIALALLSVTISFRIYKGVIQAI 245 
reticulon4C      VVDLLYWRDIKKTGVVFGASLFLLLSLTVFSIVSVTAYIALALLSVTISFRIYKGVIQAI 71 
reticulon3a      VHDLIFWRDVKKTGFVFGTTLIMLLSLAAFSVISVVSYLILALLSVTISFRIYKSVIQAV 107 
reticulon2A      VADLLYWKDTRTSGVVFTGLMVSLLCLLHFSIVSVAAHLALLLLCGTISLRVYRKVLQAV 404 
reticulon2B      VADLLYWKDTRTSGVVFTGLMVSLLCLLHFSIVSVAAHLALLLLCGTISLRVYRKVLQAV 331 
reticulon2C      VADLLYWKDTRTSGVVFTGLMVSLLCLLHFSIVSVAAHLALLLLCGTISLRVYRKVLQAV 64 
                 . **::*:* : :*.**   :. *:.*  **::**.::: *  *. ***:*:*: *:**: 
 
reticulon1A      QKTDEGHPFKAYLELEITLSQEQIQKYTDCLQFYVNSTLKELRRLFLVQDLVDSLKFAVL 708 
reticulon1C      QKTDEGHPFKAYLELEITLSQEQIQKYTDCLQFYVNSTLKELRRLFLVQDLVDSLKFAVL 140 
reticulon4A      QKSDEGHPFRAYLESEVAISEELVQKYSNSALGHVNCTIKELRRLFLVDDLVDSLKFAVL 1124 
reticulon4B      QKSDEGHPFRAYLESEVAISEELVQKYSNSALGHVNCTIKELRRLFLVDDLVDSLKFAVL 305 
reticulon4C      QKSDEGHPFRAYLESEVAISEELVQKYSNSALGHVNCTIKELRRLFLVDDLVDSLKFAVL 131 
reticulon3a      QKSEEGHPFKAYLDVDITLSSEAFHNYMNAAMVHINRALKLIIRLFLVEDLVDSLKLAVF 167 
reticulon2A      HRGDGANPFQAYLDVDLTLTREQTERLSHQITSRVVSAATQLRHFFLVEDLVDSLKLALL 464 
reticulon2B      HRGDGANPFQAYLDVDLTLTREQTERLSHQITSRVVSAATQLRHFFLVEDLVDSLKLALL 391 
reticulon2C      HRGDGANPFQAYLDVDLTLTREQTERLSHQITSRVVSAATQLRHFFLVEDLVDSLKLALL 124 






reticulon1A      MWLLTYVGALFNGLTLLLMAVVSMFTLPVVYVKHQAQIDQYLGLVRTHINAVVAKIQAKI 768 
reticulon1C      MWLLTYVGALFNGLTLLLMAVVSMFTLPVVYVKHQAQIDQYLGLVRTHINAVVAKIQAKI 200 
reticulon4A      MWVFTYVGALFNGLTLLILALISLFSVPVIYERHQAQIDHYLGLANKNVKDAMAKIQAKI 1184 
reticulon4B      MWVFTYVGALFNGLTLLILALISLFSVPVIYERHQAQIDHYLGLANKNVKDAMAKIQAKI 365 
reticulon4C      MWVFTYVGALFNGLTLLILALISLFSVPVIYERHQAQIDHYLGLANKNVKDAMAKIQAKI 191 
reticulon3a      MWLMTYVGAVFNGITLLILAELLIFSVPIVYEKYKTQIDHYVGIARDQTKSIVEKIQAKL 227 
reticulon2A      FYILTFVGAIFNGLTLLILGVIGLFTIPLLYRQHQAQIDQYVGLVTNQLSHIKAKIRAKI 524 
reticulon2B      FYILTFVGAIFNGLTLLILGVIGLFTIPLLYRQHQAQIDQYVGLVTNQLSHIKAKIRAKI 451 
reticulon2C      FYILTFVGAIFNGLTLLILGVIGLFTIPLLYRQHQAQIDQYVGLVTNQLSHIKAKIRAKI 184 
                 ::::*:***:***:***::. : :*::*::* ::::***:*:*:.  : .    **:**: 
 
reticulon1A      PG-------------AKRHAE 776 
reticulon1C      PG-------------AKRHAE 208 
reticulon4A      PG-------------LKRKAE 1192 
reticulon4B      PG-------------LKRKAE 373 
reticulon4C      PG-------------LKRKAE 199 
reticulon3a      PGI------------AKKKAE 236 
reticulon2A      PGTGALASAAAAVSGSKAKAE 545 
reticulon2B      PGTGALASAAAAVSGSKAKAE 472 
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